IRSp53 controls plasma membrane shape and polarized transport at the nascent lumen in epithelial tubules by S. Bisi et al.
ARTICLE
IRSp53 controls plasma membrane shape and
polarized transport at the nascent lumen in
epithelial tubules
Sara Bisi1,6, Stefano Marchesi1,6, Abrar Rizvi1,6, Davide Carra 1, Galina V. Beznoussenko1, Ines Ferrara2,
Gianluca Deflorian3, Alexander Mironov1, Giovanni Bertalot4, Federica Pisati3, Amanda Oldani1,
Angela Cattaneo3, Ghazaleh Saberamoli1, Salvatore Pece4,5, Giuseppe Viale4, Angela Bachi 1,
Claudio Tripodo1,2, Giorgio Scita 1,5✉ & Andrea Disanza 1
It is unclear whether the establishment of apical–basal cell polarity during the generation of
epithelial lumens requires molecules acting at the plasma membrane/actin interface. Here,
we show that the I-BAR-containing IRSp53 protein controls lumen formation and the posi-
tioning of the polarity determinants aPKC and podocalyxin. Molecularly, IRSp53 acts by
regulating the localization and activity of the small GTPase RAB35, and by interacting with
the actin capping protein EPS8. Using correlative light and electron microscopy, we further
show that IRSp53 ensures the shape and continuity of the opposing plasma membrane of two
daughter cells, leading to the formation of a single apical lumen. Genetic removal of IRSp53
results in abnormal renal tubulogenesis, with altered tubular polarity and architectural
organization. Thus, IRSp53 acts as a membrane curvature-sensing platform for the assembly
of multi-protein complexes that control the trafficking of apical determinants and the integrity
of the luminal plasma membrane.
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Many internal epithelial organs consist of a polarized cellmonolayer that surrounds a central apical lumen.Polarization requires interactions between the signaling
complexes and scaffolds that define cortical domains with
membrane-sorting machinery1. This architectural organization
and the morphogenesis processes that underlie it can be repro-
duced by plating cells on pliable matrigel in a matrigel-containing
medium that provides the mechanochemical cues for formation
of a polarized hollow sphere (cyst). The de-novo apical–basal
polarity arises from successive divisions of a single, nonpolarized
cyst-forming cell2,3. The first symmetry-breaking event occurs at
the first cell division, when the midbody is formed4. Around the
midbody, the apical membrane initiation site (AMIS) is assem-
bled, which establishes the location of the nascent lumen.
Assembly of the AMIS is mediated by both microtubules and
branched actin filaments, which promote recruitment and
anchoring of vesicles5. Transmembrane proteins, such as podo-
calyxin (PODXL; classical apical marker, also known as GP135)
and Crumbs3, are transcytosed from the plasma membrane
facing the extracellular matrix (ECM) toward the first cell–cell
contact site6. This occurs via RAB11-RAB8 endo/exosomes traf-
ficking and through a direct anchoring with RAB35 at the
AMIS6,7. Thus, coordination between actin cytoskeletal dynamics
and membrane trafficking is essential for the initiation of a
polarized central lumen.
The molecular players that link the spatially restricted actin
dynamics and the polarized delivery of endosomal vesicles remain
incompletely understood. What determines the shape of the
opposing apical membrane during the initial phase of lumeno-
genesis is also not clear. Proteins that can sense and shape the
curvature of the plasma membrane at the AMIS and physically
link it with the underlying cytoskeleton will be critical here. We
postulated that IRSp53 can fulfill this function.
IRSp53 regulates the interplay between the plasma membrane
and the actin cytoskeleton during directional migration and
invasion of cells8–11. Accordingly, IRSp53 localizes at the tips of
both filopodia and lamellipodia12. At these sites, IRSp53 senses
and promotes membrane curvature through its I-BAR domain,
and acts as an effector of either CDC42 or RAC1 GTPases by
ensuring the recruitment of a number of actin regulatory
proteins8,9,13–17. These proteins include the nucleator-promoting
WAVE complex, essential for branched polymerization of actin,
and the linear actin elongators VASP and mDia1, which together
with EPS8 (an actin capping and cross-linking protein18) initiate
and promote the extension of filopodia8,19,20. Through its I-BAR
domain, IRSp53 undergoes a phase separation that facilitates
protein clustering21 and the recruitment of Ezrin, a member of
the ezrin-radixin-moesin (ERM) protein family, that links the
actin cortex to the cell membranes22. The subsequent binding of
activated CDC42 to this cluster leads to inhibition of the weak
capping activity of IRSp53. It further promotes a structural
change in IRSp53 that facilitates the interaction of IRSp53, via its
now-liberated SH3 domain, with actin linear elongators and
cross-linkers to support the growth of filopodia8,23. IRSp53 has
also been involved in the assembly of cell–cell and cell–ECM
adhesions downstream of “polarity-regulating kinase
partitioning-defective 1b” (PAR1B), and in the polarized archi-
tectural organization of Madin Darby canine kidney (MDCK)
epithelial cells in vitro24,25. The molecular pathways and inter-
actors IRSp53 uses in these processes and their physiological
relevance at the organism level, however, remains poorly
understood.
Here, we investigated these issues using three-dimensional
cultures of renal MDCK and intestinal Caco-2 cysts, as well as
genetically modified zebrafish and mice. Our data indicate that
IRSp53 is pivotal for the assembly of the RAB35–IRSp53–EPS8
macromolecular complex. We further show that this complex is
necessary for correct kidney morphogenesis and lumenogenesis,
through its control of polarized transport and the shape of the
apical plasma membrane.
Results
IRSp53 localizes to the apical lumen in vivo and in vitro. To
study the physiological role of IRSp53 in epithelial morphogen-
esis, we examined its expression (Supplementary Fig. 1A) and
localization in several epithelial tissues characterized by glandular
or tubular structures (Fig. 1a–d). Invariably, IRSp53 localized to
the luminal-facing side of the human epithelial cells in human
(Fig. 1a, b), adult mice (Fig. 1c), and in the pronephric ducts of
developing zebrafish (Fig. 1d). We confirm the apical localization
of endogenous IRSp53, as well as of expressed GFP-IRSp53 in
two-dimensional (2D) monolayers and 3D cysts of MDCK
(Fig. 2a and Supplementary Fig. 2A) and colorectal adenocarci-
noma (Caco-2) epithelial (Supplementary Fig. 2B–C) cells
in vitro.
The loss of IRSp53 disrupts cyst morphogenesis. To determine
whether IRSp53 is involved in the establishment of apical–basal
polarity and lumen formation, IRSp53 was depleted in MDCK
cells using CRISPR/Cas9, shRNA24, and siRNAs, and in Caco-2
cells using CRISPR/Cas9. Single MDCK-control and IRSp53-
depleted cells were seeded onto Matrigel for 6 days to allow the
generation of hollow cysts1,26. As expected, most of the control
cysts (>75%) developed a single, actin-positive central lumen that
was surrounded by an epithelial monolayer, which was decorated
by apical proteins, such as PODXL (Fig. 2b). Conversely, <50% of
the MDCK IRSp53-silenced cysts formed a single apical lumen,
while the remaining showed either multiple or aberrant lumens
(Fig. 2b). A significant increase in multi-luminal aberrant cysts
was also seen in two independently generated Caco-2 cell
CRISPR–IRSp53-KO clones, as compared to the control Caco-2
cells (Fig. 2c). The aberrant multi-luminal phenotype was rescued
upon re-expression of GFP-IRSp53 in both the IRSp53-silenced
MDCK and Caco-2 IRSp53-KO cells (Fig. 2c). Thus, IRSp53 has a
crucial role in the morphogenesis of these epithelial organoids.
IRSp53 controls the distribution and trafficking of PODXL.
Next, we examined the localization and dynamics of IRSp53 in
the very early phases of cystogenesis (Fig. 3a)6. In the first 8–12 h
after plating of the control cells, PODXL localized to the per-
ipheral surface of the cells, before accumulating in vesicular-like,
recycling structures, as previously shown7,27–31. Subsequently,
PODXL was delivered to the opposing membrane between the
two daughter cells, where the apical lumen was formed de novo
(Fig. 3a, b). IRSp53 became prominently enriched along the newly
formed, opposing intercellular membrane well before PODXL
recruitment (Fig. 3b, Supplementary Movie 1). At later stages,
IRSp53 and PODXL were concentrated at the AMIS, and when
the cyst was formed, IRSp53 and PODXL co-stained along the
lumen (Fig. 3b). In the early phases of cystogenesis, IRSp53 and
PODXL also co-localized in vesicle-like structures (Fig. 3b),
which, after forming at the peripheral plasma membrane, were
subsequently internalized and targeted to the AMIS and the
nascent lumen (Fig. 3c–d, Supplementary Movies 2 and 3). These
findings suggest that IRSp53 and PODXL co-traffic to or from
endosomal recycling compartments and that IRSp53 controls the
trafficking or targeting of PODXL to the AMIS.
To distinguish among these possibilities, we analyze the cellular
localization of GFP-IRSp53 relative to a variety of proteins that
mark distinct trafficking compartments. GFP-IRSp53, which
showed a distribution identical to that of the endogenous protein
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(Fig. 2a, and Supplementary Fig. 2A), partially localized with
PODXL and actin in vesicle-like structures (Fig. 4a). These
structures were also positive for RAB7, RAB11a, and RAB35
(Fig. 4a), but not for the early and late endosome markers “early
endosome antigen 1” (EEA1) and “lysosome-associated
membrane glycoprotein 1” (LAMP1), respectively, or the Golgi
marker Giantin (Supplementary Fig. S2D).
To determine whether IRSp53 is involved in the control of
PODXL trafficking, we took advantage of the observation that
PODXL is internalized from the apical membrane and undergoes
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trafficking to the so-called vacuolar apical compartment (VAC)
upon calcium removal in MDCK polarized monolayers32. To
verify that PODXL is internalized under these conditions, MDCK
cell monolayers were incubated with a PODXL antibody that
recognized the extracellular portion of PODXL in vivo. Detection
of PODXL with a secondary fluorescence-conjugated anti-
PODXL IgG after stripping of the cell surface with acid washes
revealed that PODXL was internalized in the VACs (Supplemen-
tary Fig. 3A). Of note, IRSp53 and PODXL colocalize at VACs
upon calcium removal in polarized monolayer (Supplementary
Fig. 3B). The removal of IRSp53 significantly delayed the
relocalization of PODXL to the VACs, in comparison to the
control cells (Supplementary Fig. S3C–E).
If IRSp53 is required for correct trafficking or anchoring of
PODXL in the early phases of cystogenesis, its ablation should
lead to mislocalization of PODXL. Consistently, while in control
cells PODXL was enriched in a single, centrally-located luminal
spot at the four-cell stage, in the IRSp53-KO and knocked-down
cells, we detected two or more PODXL-positive foci (Fig. 4b, c).
Of note, the majority of IRSp53-silenced, early phase, multi-
luminal cysts retained an apically-restricted distribution of
PODXL. However, a significant, albeit small, proportion of the
cysts showed an inverted apical–basal polarity that was
characterized by mislocalization of PODXL to the outer, ECM-
facing, plasma membrane (Fig. 4b, c). We performed a similar
experiment also in IRSp53-KO Caco-2 cells by monitoring the
distribution of aPKC, which is the most commonly-used apical
marker in this cell system26,33,34. Likewise in MDCK cells, IRSp53
depletion resulted in formation of aPKC multi-foci at the 3–4-cell
stage during cystogenesis, as compared to the control Caco-2 cells
(Supplementary Fig. 4A).
Collectively, these findings indicate that IRSp53 is implicated in
the trafficking and/or correct targeting of apical proteins, and
specifically of PODXL, to the de-novo forming lumen.
IRSp53 coordinates RAB35 and EPS8 pathways in lumen for-
mation. The RAB GTPases are key regulators of PODXL trans-
cytosis35. Among these, we focused our attention on RAB35.
RAB35 is involved in clathrin-mediated endocytosis36 and was
recently shown to localize early at the AMIS, where it serves as a
physical anchor for the targeting of PODXL in MDCK cell
cystogenesis7,35. Of note, the complete genetic loss of RAB35 was
shown to lead to a complete but transient inversion of polarity
accompanied by accumulation of PODXL in intracellular vesicles
and only subsequently to the formation of multilumen32. Con-
versely, a partial reduction of its expression caused the formation
of multiple lumen10. Collectively, these findings indicate that
tampering with RAB35 activity impact on cystogenesis, PODXL
trafficking and establishment of apico-basal polarity.
During the initial phases of cyst development, IRSp53 and
RAB35 were enriched along the opposing cell–cell membrane
prior to the arrival of PODXL (Fig. 3b and Supplementary
Fig. 4B). At the later stages, IRSp53, RAB35, and PODXL were
concentrated at the AMIS (Fig. 3b and Supplementary Fig. 4B).
IRSp53, RAB35, and PODXL also colocalized in intracellular
vesicle-like structures (Figs. 3b and 4a, and Supplementary
Fig. 4B). More relevantly, silencing of RAB35, as previously
reported7,35 and partly reproduced by IRSp53 depletion, resulted
in the complete inversion of the apical–basal polarity and in the
formation of multi-lumen cysts (Fig. 4c). The penetrance of
polarity inversion caused by the silencing of IRSp53 (Fig. 4b) is
almost as robust as in the case of RAB35 loss. This is, however,
expected since IRSp53 only partially affects RAB35 localization
and activity and further impacts on other independent pathways
(see below). Stated differently, the loss of IRSp53 mimics a partial
loss of RAB35 function in epithelial polarity. Notably, IRSp53
retained its localization to the AMIS in RAB35-silenced cells that
showed inverted PODXL polarity (Supplementary Fig. 4C).
To determine whether IRSp53 and RAB35 interact physically,
co-immunoprecipitation experiments were performed. Here,
ectopically expressed IRSp53 interacted with RAB35 only upon
serum starvation, which suggested that IRSp53 might preferen-
tially associate with the inactive GDP-bound form of RAB35
(Fig. 5a). This possibility was verified using the recombinant
purified dominant-negative RAB35S22N and constitutively active
RAB35Q67L mutants of RAB35, and the recombinant purified
RAB35WT, loaded either with GDP or GTPγS, in in vitro pull
down and overlay assays. Here, IRSp53 bound directly, albeit
weakly to RAB35 and, surprisingly, showed higher apparent
affinity for inactive RAB35S22N or RAB35WT-GDP compared to
the RAB35Q67L or RAB35WT-GTP forms respectively (Supple-
mentary Fig. 4D, E). Mapping of the interaction surfaces showed
that the I-BAR domain of IRSp53 is necessary and sufficient for
this association with RAB35S22N (Fig. 5b). In addition, an
IRSp53 mutant that lacked these critical positively charged
residues (the I-BAR-4K domain mutant; IRSp53 I-BAR*: K142E,
K143E, K146E, K147E37) did not interact with RAB35S22N
under in vitro binding or co-immunoprecipitation conditions
(Fig. 5c, d).
The direct interaction between IRSp53 and RAB35 suggested
that these two proteins might function together in the regulation
of PODXL localization during cystogenesis. Thus, perturbation of
their association should affect PODXL trafficking to the AMIS
and lumenogenesis. To test this, we lentivirally transduced
IRSp53 mutants in each of its critical domains (i.e., I-BAR,
CRIB, SH3, PDZ-binding domains)10 into IRSp53-silenced
MDCK cells and IRSp53-KO Caco-2 cells and performed
cystogenesis assays to examine PODXL and aPKC localization.
Expression of the I-BAR-4K mutant, which retains its structural
integrity37 but does not bind to RAB35 failed in rescuing the
localization of PODXL to a single spot at the AMIS in these
MDCK cells (Fig. 5e). This mutant was still present on the apical
lumen, albeit its localization was more diffuse and less restricted
than wild-type (WT) IRSp53 (see also below). Similar findings
were obtained upon expression of I-BAR-4K in Caco-2 IRSp53-
KO cells (Supplementary Fig. 5A). Furthermore, in the Caco-2
IRSp53-KO cells, analysis of the IRSp53 mutants showed that the
I-BAR and SH3 domains were essential for correct IRSp53
localization at the apical lumen (Fig. 6a). Thus, IRSp53 required
its functional I-BAR domain for its role in lumen formation in
Fig. 1 IRSp53 is restricted to the luminal side in various epithelial tissues of vertebrates. a IHC analysis of IRSp53 expression and localization in the
indicated human tissues and organs. Arrowheads indicate the apical/luminal enrichment of IRSp53. Scale bar, 50 µm. b IF analysis of human kidney.
Samples were stained with anti-IRSp53 (red), anti-Laminin (green) and DAPI (upper panels) or with anti-IRSp53 (red) anti-ZO-1 (green) and DAPI (lower
panels). Arrowheads and arrows indicate the apical/luminal localization of IRSp53 and ZO-1, or the basal enrichment of Laminin, respectively. Scale bar, 50
µm. c IHC analysis of the expression and localization of IRSp53 in the indicated murine tissues and organs. Arrowheads indicate the apical/luminal
enrichment of IRSp53. Scale bar, 20 µm. d IHC analysis of Baiap2a and Baiap2b expression and localization in zebrafish embryo (Inset: PD) at 72 hpf in the
indicated genetic backgrounds: baiap2a wild-type (b2a WT), baiap2a mutant (b2a −/−), baiap2b morphant (b2a WT b2b_Mo) and baiap2a mutant baiap2b
morphant (b2a −/− b2b_Mo). Arrowheads indicate the apical/luminal enrichment of IRSp53 in the pronephric duct. Scale bar, 50 µm (insets, 200 µm).
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these epithelial cells. Molecularly, both its binding to negatively
curved, phosphatidylinositol 4,5-bis phosphate (Ptdins(4,5)P2)-
rich membranes (which is compromised by the mutations
inserted37), and its interactions with RAB35 are likely to account
for these findings. Consistently, IRSp53 ablation impaired the
localization of RAB35 (Fig. 6b) and of RAB35S22N (Supplemen-
tary Fig. 4F) at the nascent AMIS during the early phases of
cystogenesis. Caution should, however, be used in interpreting the
finding with RAB35S22N since its expression also perturbs the
correct formation of a lumen and PODXL anchoring to the
AMIS7. This notwithstanding, IRSp53 acts as an assembly
platform that drives the correct localization of RAB35, and
possibly its activation, at this site. To directly address this, we
measured the amount of GTP-loaded RAB35 using immobilized
RAB35-binding domain of RUSC238. The loss of IRSp53 reduced
the levels of active RAB35 (Fig. 6c). Altogether, these findings
point to a role of IRSp53 in promoting the optimal localization
and activity of RAB35.
The structure-function analysis further indicated the require-
ment of additional domains of IRSp53 for correct cyst
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morphogenesis. Indeed, IRSp53 mutations in either the CRIB-PP
region (required for IRSp53 binding to active CDC428,9,16,23) or
the SH3 domain (which mediates interactions with a variety of
IRSp53 binding partners8,9,15,16,20,23,39) failed to rescue the
defective distribution of PODXL in MDCK cells and lumen
formation in Caco-2 cells, respectively, that arose from the
IRSp53 ablation (Fig. 5e and Supplementary Fig. 5A). Noticeably,
impairing the function of the SH3 domain also altered the
luminal localization of IRSp53 (Fig. 6a). This was particularly
evident in the Caco-2 cysts. In this system, IRSp53 showed a
restricted, although evenly distributed, localization along the
apical, luminal side. Conversely, an IRSp53-SH3-defective mutant
focally accumulated to tight junctions, where it colocalized with
ZO-1, with its continuous apical distribution lost (Fig. 6a). These
results indicate that beside the I-BAR interaction with RAB35,
SH3 interactors are also likely to be important in coordination of
IRSp53 localization and activity. Among these, the actin capping
and bundling protein EPS8 was previously shown to form a
stoichiometrically stable complex with IRSp53 in vivo9. Thus, we
investigated the involvement of EPS8 together with IRSp53 in
orchestration of the correct lumenogenesis program. Here, we
show that: (a) EPS8, like IRSp53, is recruited early at the AMIS
(Supplementary Fig. 5B) and has an apically restricted luminal
localization in MDCK cells (Supplementary Fig. 5C) and Caco-2
cysts (Supplementary Fig 5D); (b) loss of EPS8 in Caco-2 cells
leads to the formation of cysts with multiple lumens and, at less
extent, inverted of polarity (Supplementary Fig. 6A, B); (c) EPS8
is required for the correct localization of IRSp53 but not the
opposite (Fig. 6d and Supplementary Fig. 6D).
IRSp53 shapes the plasma membrane at nascent lumens. Our
findings argue that IRSp53 controls epithelial tissue polarity and
lumenogenesis in vitro through the regulation of polarized traf-
ficking and by acting as a scaffold for the assembly of apically
restricted RAB35 and EPS8 complexes (Fig. 6e). However, IRSp53
can also sense and control membrane curvature and local phos-
pholipid composition through its I-BAR domain, which will
ultimately impact on the ultrastructural organization and shape of
the plasma membrane at the nascent AMIS. To investigate this
possibility, we performed correlative light and electron micro-
scopy analysis in the very early phases of cystogenesis, which was
monitored by the appearance at the AMIS of β-catenin and, more
importantly, of PODXL (Fig. 7a, Supplementary Figs. 7 and 8).
We focused on the two-cell stage of MDCK cells plated onto a
Matrigel cushion. Comparison between the MDCK control (Ctr)
and the IRSp53-KO cells showed that loss of IRSp53 delays or
blocks the elimination of cytoplasmic bridges between newly
formed apical domains at the AMIS (Fig. 7a, b) where IRSp53 is
relocalized even before PODXL (Fig. 2b, Supplementary Fig. 4B
and Fig. 7). Also, albeit less frequently, this impacted on the
intercellular luminal space (Fig. 7a), and resulted in the formation
of PODXL-positive ectopic lumens (cytoplasmic membrane
vacuoles with features of apical domains) (Supplementary Fig. 8).
Of particular significance, there was the occasional but evident
reduction of intercellular space and a significant increase in the
number of “cytoplasmic bridges” that interrupted the separation
of the luminal (apical) plasma membrane of two adjacent IRSp53-
KO cells (Fig. 7a, b). These were also visible in tomographic 3D
reconstructions (Fig. 7B; Supplementary Movie 4). Thus, IRSp53
ensures the integrity and structural organization of the plasma
membrane at the AMIS. The increased number of membrane
interconnections, caused by the loss of IRSp53 might generate
distinct “mini-lumens” and plasma membrane targeting sites.
These defects together with altered polarized trafficking of
PODXL carriers, also enriched in IRSp53 (Supplementary Fig. 7),
might lead the accumulation of PODXL in multiple foci, which
would eventually evolve into multiple lumens.
IRSp53 is required for kidney development and morphology.
To determine the functional activity of IRSp53 is physiologically
relevant in living organisms, zebrafish lines were generated that
carry a mutation in the fish paralog, baiap2a (b2a), and mor-
pholinos were used to ablate baiap2b (b2b) (see below). More-
over, we analyzed tissue organization in IRSp53-KO mice. In both
of these models, IRSp53 showed prominent expression and
peculiar luminal localization in the kidneys. In the renal tubules
of adult mice, IRSp53 was expressed and enriched at the luminal
side (Fig. 1c). A similar, restricted pattern of luminal apical
expression was seen in early-stage pronephric ducts in developing
fish embryos (Fig. 1d). The analysis was therefore focused on this
organ, and specifically on its tubular architecture. In zebrafish,
gene duplication resulted in the generation of two distinct, but
highly related, IRSp53 paralogs known as baiap2a (b2a) and
baiap2b (b2b). These two gene products are expressed at variable
levels in the developing embryo, with b2a as the more expressed
(Supplementary Fig. 1B). A mutant zebrafish line was generated
in which the gene product encoding for b2a was disrupted
through introduction of a chemically-mediated nonsense muta-
tion (Supplementary Fig. 1C), with that for b2b targeted using a
mixture of splice and translation blocking morpholinos (Sup-
plementary Fig. 1C). We also characterized an antibody that can
recognize both b2a and b2b, at least when expressed in mam-
malian cells (Supplementary Fig. 1D). The loss of b2a in the
mutant line caused a large reduction in the expression of IRSp53
in the pronephric ducts, which was consistent with b2a being
Fig. 2 IRSp53 removal increased the formation of cysts with multiple lumens. a Three days old MDCK epithelial cysts were fixed and stained an anti-
IRSp53 antibody (green), and rhodamine phalloidin (red) to visualized F-actin and DAPI (blue). Arrows indicate IRSp53 and F-actin at the luminal side of
the cyst. Scale bar, 18 µm. b Five days old 3D cysts of MDCK control cells (IRSp53 Ctr) or IRSp53-KO obtained by CRISPR/Cas9, or MDCK control (MDCK
Ctr) or IRSp53-KD (not shown). Left: the cysts were stained with anti-podocalyxin (PODXL, red) and DAPI (blue). Asterisks, multiple lumens in IRSp53-KO
cyst. Scale bar, 18 µm. Central: quantification of cysts with multiple lumens in IRSp53 Ctr vs IRSp53-KO (Top) or IRSp53 Ctr vs IRSp53-KD (Bottom). Data
are expressed as means ± SD. At least 20 cysts/experiment were analysed in n= 6 (IRSp53 Ctr), n= 4 (IRSp53-KO) or n= 4 (IRSp53 Ctr and IRSp53-KD)
independent experiments. P value, student’s t-test two-tailed. **p < 0.01; ***p < 0.001. Source data are provided as a Source Data file. Right: IRSp53 and
vinculin protein levels. Mw Molecular weight markers. c Top left: 3D cysts embedded into Matrigel/ collagen matrix of Caco-2 control (Ctr) or IRSp53-KO
clones #3 and #12 cells, obtained by CRISPR/Cas9 were stained with an anti-atypical-PKC antibody (a-PKC, green), rhodamine-phalloidin to detect F-actin
(red) and DAPI (blue). Asterisks, multi-lumens in IRSp53-KO cyst. Scale bar, 10 µm. Top right: 3D cysts from IRSp53-KO clone #3 stably-infected to
express GFP or murine GFP-IRSp53 cells were processed for epifluorescence to visualize GFP or GFP-IRSp53 and stained with rhodamine-phalloidin to
detect F-actin (red) and DAPI (blue). Asterisks, multiple lumens in IRSp53-KO GFP cyst. Scale bar, 10 µm. Lower left: Quantification of cysts with multiple
lumens. Data are expressed as mean ± SD. At least 25 cysts/experiment were analysed in n= 2 independent experiments. P value, student’s t-test two-
tailed. *p < 0.05; **p < 0.01. Source data are provided as a Source Data file. Lower right: IRSp53 and vinculin protein levels (for GFP and GFP-IRSp53 levels-
Supplementary Fig. S5A). Residual expression of IRSp53 in clones #3 and #12 is due to the aneuploidy of Caco-2 cells (see “Methods”).
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Fig. 3 IRSP53 precedes PODXL localization to the apical membrane. a Schematic representation of IRSp53 and PODXL trafficking during the early phases
of lumenogenesis. b MDCK cells expressing GFP-IRSp53 were seeded as single cells on a Matrigel layer and left to grow to form three-dimensional (3D)
cysts. The cysts were fixed at the indicated time points, processed for epifluorescence to visualize GFP-IRSp53 (green) and stained with anti-PODXL (red)
and DAPI (blue). Arrowheads, IRSp53 preceding PODXL relocalization at the AMIS at early time points; colocalization of IRSp53 and PODXL at the AMIS at
later time points; and enrichment at the luminal side in the mature cyst. Arrows, IRSp53 and PODXL colocalization in vesicle-like structures. Scale bar, 18
µm. c, d Still images of time lapse of GFP-IRSp53 during early phases of cystogenesis. MDCK expressing GFP-IRSp53 were seeded as single cells on a
Matrigel. 6 h after seeding cells were subjected to time-lapse analysis using Confocal Spinning Disk microscope. Images (Bright Field and GFP channel
respectively) were acquired every 5 min for 15 h (see also Supplementary Movies 2 and 3). White arrowheads indicate GFP-IRSp53 vesicular-like structures
that emerge from the peripheral plasma membrane and move toward the inner (c) or the forming apical side at cleavage furrow immediately after the first
cell division (d). Scale bar, 10 µm.
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more expressed than b2b, albeit we cannot rule out that b2b was
also present (Fig. 1d).
To visualize the pronephric duct during development, the WT
(b2a WT) and mutant b2a (b2a −/−) lines were crossed with Tg
(CldnB::GFP). This transgenic line expresses EGFP under the
control of the promoter of ClaudinB, which is localized in various
epithelial structures, including the developing kidneys40. Indivi-
dual depletion of the single baiap2 genes, so in the b2a mutant
line or by injection of the b2b-morpholino in WT embryos, did
not interfere with normal pronephric duct development (Fig. 8a,
Supplementary Fig. 9A, B and Supplementary Fig. 10A). How-
ever, injection of b2b morpholinos in the b2a mutant lines caused
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alterations in the structure of the pronephric ducts. These ducts
were less compact and dense (Supplementary Fig. 9A), with
irregular or multiple lumens (Supplementary Fig. 9B) and
frequently (in ~67% of embryos) showed the formation of
ectopic ClaudinB-positive structures emerging from their basal
surfaces (Fig. 8a, Supplementary Fig. 9B, Supplementary Fig. 10A,
and Supplementary Movie 5). The multiple lumens and ectopic
pseudo-lumenized structures characterized by irregular and
diffused acetylated-tubulin and F-actin distributions (Supple-
mentary Fig. 9B and Supplementary Fig. 10A) were reminiscent
of the defects observed in mammalian organoids devoid of
IRSp53 caused by perturbation of the correct polarity program.
Despite the absence of an overt phenotypic alteration in the
pronephric ducts of singly mutated b2a embryos, we reasoned
that in adult life, aging-dependence or environmental stresses
might combine with the genetic alterations to cause phenotypic
perturbations that are not visible during development. Consis-
tently, histological analysis of adult zebrafish kidneys at various
ages (e.g., 4, 8 months) showed several morphological defects in
the kidneys of the adult b2a mutant line (Fig. 8b). The general
architecture of the organs of the b2a mutants was altered, with a
decrease in the density of the tubules and a relative increase in the
epithelial-to-hematopoietic cell ratio, compared to those of age-
matched WT animals (Fig. 8b). This was accompanied by
vascular lacunae and defects in the architectural organization of
the renal tubules, which were frequently coarsed or lacked an
overt lumen (Fig. 8b).
Prompted by these observations, we examined the renal
architecture in the IRSp53-KO mice. IRSp53-KO mice have a
partially penetrant mid-gestation lethality that is due to defects in
placental morphogenesis, as previously reported41. Some 20% to
25% of these mice, however, are born fertile and devoid of gross
tissue dysmorphology8,42,43. Histopathological and immunohis-
tochemical analyses of renal tissues of the IRSP53-KO mice,
however, showed some relatively mild, but evident and recurrent,
alterations that were reminiscent of those in the kidneys and
tubules of the adult B2a mutant zebrafish (Fig. 9, Supplementary
Fig. 10B). The overall morphology of the IRSp53-KO mouse
kidneys was defective, with thinning of the cortex despite
preserved glomerular density. The renal proximal tubules showed
irregular contours that resulted in ill-defined lumina lined by
irregularly spaced epithelial cells with prominent nuclear
dysmorphism (Fig. 9a). Similar architectural alterations were
seen in the distal tubules. Focal periodic acid Schiff–positive
urinary casts were detected in the IRSp53-KO mouse kidney
parenchyma (Supplementary Fig. 11A). In addition, the glomeruli
of these IRSp53-KO mice showed alterations in the capillary tufts,
because of multifocal pseudo-aneurismatic vascular dilations and/
or mesangial cell proliferation (Fig. 9a). The severity of these
phenotypes was scored using a histological alteration score
(Fig. 9b, Supplementary Fig. 10B). Immunohistochemistry
analysis of both apical and basal epithelial renal markers further
highlighted defects in the epithelial tubular cell apical–basal
polarity, as shown by the following findings (Supplementary
Fig. 11B–D): (i) ZO-1, which labeled tight apical junctions in
most tubules of the control kidney, was diffuse or reduced in
IRSp53-KO kidney tubules (Supplementary Fig. 11B); (ii)
similarly, the apical label aPKCζ was diminished, and was
sometimes absent from the lumen of mutant animals (Supple-
mentary Fig. 11C); (iii) endomucin, which localizes to the basal
side of tubules in the controls, remained largely basal when
expressed, but was irregularly distributed and sometimes absent
in the IRSp53-KO tubules (Supplementary Fig. 11D).
Altogether these data indicate that IRSp53 loss results in a set
of subclinical morphological and histological aberrancies in the
developing kidney and in adult renal tubules in zebrafish and
mice, by impinging on, at least in part, the correct establishment
or maintenance of epithelial polarity.
Discussion
During the development of tubular or glandular structures of
epithelial tissues, and specifically of kidneys, de-novo formation
of a polarized central lumen is a key step that requires spatio-
temporally coordinated interplay between actin cytoskeleton
dynamics and targeted exocytosis of apical cargos, such as
PODXL31. Although the molecular players that coordinate these
events have been intensely studied44, we still do not have a
complete mechanistic understanding of this process. In addition,
whether the knowledge gleaned from the analysis of in vitro
morphogenesis of multicellular systems, such as cysts derived
from MDCK or Caco-2 cells1,26,27,45–47, is physiologically rele-
vant in vivo for the development of complex organs has not been
systematically tested.
Here, we show that IRSp53, a CDC42 effector that can sense
Ptdins(4,5)P2-rich negative membrane curvature8,10,23–25, acts as
a platform for the assembly, integration, and spatial restriction of
multiple complexes that are needed for correct formation of the
polarized single lumen in various epithelial systems in vitro. We
further show that IRSp53 is critical in the shaping of the plasma
membrane, and to ensure its integrity and continuity in the
nascent lumen (Fig. 10). These functional roles in in vitro systems
are mirrored by the requirement for IRSp53 for correct mor-
phogenesis and structural organization of kidney tubules in mice
Fig. 4 Loss of IRSp53 alters PODXL trafficking at the AMIS and apical–basal polarity. a Left: MDCK cells, expressing GFP-IRSp53, were mock
transfected or transfected with Apple-RAB11a or RFP-RAB35, and seeded as single cells on Matrigel and fixed after 5 h of growth. Cysts were processed for
epifluorescence to visualize GFP-IRSp53 (green) and Apple-RAB11a or RFP-RAB35, or stained with rhodamine-phalloidin (red), anti-PODXL (red) or anti-7
(red), and DAPI (blue). Arrowheads, IRSp53 colocalization with trafficking markers. Scale bar, 10 µm. Right: Intensity profiles of the green and red channels
over the vesicular structures (dashed lines in the merge channels). b Top: MDCK cell control (Ctr) and IRSp53-KO were seeded as single cells on Matrigel
and grown for 24/36 h. The cysts were stained with anti-β-catenin (green) and anti-PODXL (red) antibodies, and DAPI (blue). Asterisks, PODXL multi-foci
in IRSp53-KO cyst. Arrowheads, PODXL staining at the basal membrane in IRSp53-KO cyst. Scale bar, 10 µm. Bottom: Quantification of multi-foci cysts
(left) and inverted polarity cysts (right). Data are means ± SD. Four-cell stage cysts were analysed, as at least 20 cysts/experiment in n= 7 (Ctr) and n= 5
(IRSp53-KO) independent experiments. P value, student’s t-test two-tailed (multi-foci) or one-tailed (inverted polarity). *p < 0.05; ***p < 0.001. Source
data are provided as a Source Data file. c Top: MDCK control (Ctr), IRSp53-KD or RAB35-KD cells were seeded as single cells on a Matrigel and grown for
24/36 h. The cysts were fixed and stained with anti-β-catenin (green) and anti-PODXL (red) antibodies, and DAPI (blue). Asterisks, PODXL multi-foci in
IRSp53-KD and RAB35-KD cysts. Arrowheads, PODXL staining at the basal membrane in IRSp53-KD and RAB35-KD cysts. Scale bar, 10 µm. Bottom left:
Quantification of multi-foci cysts (left) and inverted polarity cysts (right). Data are means ± SD. Four-cell stage cysts were analysed, as at least 20 cysts/
experiment in n= 7 (Ctr; IRSp53-KD) and n= 3 (RAB35-KD) (multi-foci) or n= 7 (Ctr), n= 4 (IRSp53-KD) and n= 2 (RAB35-KD) (inverted polarity)
independent experiments. P value, student’s t-test two-tailed (multi-foci) or one-tailed (inverted polarity). *p < 0.05; ***p < 0.001. Source data are provided
as a Source Data file. Bottom right: immunoblotting of IRSp53, RAB35 and vinculin levels.
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and zebrafish, where it controls the appropriate distribution of
different polarity determinants.
Topologically, IRSp53 is apically restricted at the luminal
membrane side of tubular and glandular epithelial tissues in
human, murine, and zebrafish, and in 3D epithelial acini in vitro.
This apically restricted localization is particularly prominent in
adult murine and human kidney tubules, and in the pronephric
ducts of zebrafish during development. Depletion of IRSp53
disrupts cystogenesis in vitro, which leads to multi-lumen for-
mation and inversion of polarity. A remarkably similar set of
alterations, which includes formation of multiple lumens and of
ectopic structures that have lost their stereotypical apical–basal
morphology, are also observed in the pronephric duct after
genetic removal of the two zebrafish paralogs of mammalian
IRSp53. Renal tubules in IRSp53-KO mice are convoluted, not
patent, and frequently display an aberrant distribution of the
epithelial cells that normally surround the lumen in an orderly
and stereotypical pattern. The latter phenotypes correlate with
incorrect distribution of various apical determinants, including
ZO-1 and aPKC. Collectively, these findings support the crucial
involvement of IRSp53 in renal lumenogenesis and tubule mor-
phogenesis across different species.
The relatively mild tubular defects in adult organisms appear to
reflect the plasticity of the epithelial morphogenesis processes,
which can use multiple, and often redundant, molecular pathways
to ensure maintenance of the correctly organized structure and
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the functional activity of the tissues. In keeping with this concept,
the genetic loss of another member of the I-BAR family proteins,
known as “missing-in metastasis” (MIM, also known as MTSS1),
was shown to impact on adult kidney architecture through reg-
ulation of intercellular junctions. MIM−/− mice show a pro-
gressive kidney pathological diseased state with dilated tubules,
glomerular degeneration, and fibrosis. This set of alterations is
accompanied by polyuria at the systemic level, whereas increased
intercellular junctional spaces are detected by ultrastructural
electron microscopy analysis48. Thus, different members of the I-
BAR family proteins contribute to the proper structural organi-
zation of adult murine kidney, with these partly acting in a
redundant fashion48. It is also of note that some of the alterations
due to loss of IRSp53 are observed in mice devoid of key com-
ponents of the molecular network of the IRSp53 interactors. A
case in point is CDC42, which has a pivotal role in virtually all
polarized cell processes in diverse epithelial and non-epithelial
tissues by acting as a central signaling hub that connects actin
dynamics, vesicular trafficking, and membrane remodeling1,49.
Indeed, genetic loss of CDC42 in murine kidney tubules during
development leads to abnormal tubulogenesis with profound
defects in polarity, lumen formation, and the actin cytoskeleton,
which eventually result in premature death of these animals50–52.
These alterations are significantly more severe than those detected
in IRSp53-KO mice, which is in keeping with the concept that
CDC42 is a central hub that coordinates and uses multiple
effectors and pathways to control polarity. Among these, IRSp53
appears to contribute to interconnecting of the CDC42 axis with
RAB35/PODXL trafficking and EPS8-based actin dynamics.
However, other CDC42-dependent pathways, such as Ptdins(4,5)
P2-Annexin-CDC4253, CDC42-PAR3-aPKC54, and CDC42/
YAP152 are expected to remain functional following disruption of
IRSp53, and might, therefore, compensate for the lack of IRSp53.
Redundancy and compensation mechanisms of IRSp53 func-
tions might also be at play in processes and pathways that control
endocytic internalization of PODXL, inversion of polarity and
Robo2-p53 axis, which, as described in the Supplementary dis-
cussion, have been implicated in the correct lumenogenesis and
renal tubule formation.
At the cellular level, during 3D cystogenesis, the loss of IRSp53
leads to formation of multiple lumens and reversal of polarity,
albeit less frequently. The formation of multiple lumens occurs
frequently following disruption of a variety of trafficking, polarity,
and cytokinetic regulators. This indicates that none of these
processes is essential for establishment of apical–basal epithelial
polarity; rather, they all contribute to ensure the formation of the
single AMIS that will eventually generate a single lumen. In the
case of IRSp53, its loss is likely to impact on the optimal func-
tionality of many of these critical cell-biology processes. Indeed,
IRSp53 is recruited very early on, at the onset of AMIS formation,
which appears to be as a consequence of its I-BAR domain sen-
sing of Ptdins(4,5)P2-rich, negative membrane curvature that is a
distinguishing early feature during de-novo formation of the
AMIS around the midbody immediately after completion of the
first cytokinesis5,53. At this site, and similar to what is seen in
extending protrusions of migratory cells12,55–59, IRSp53 accu-
mulates together with its interactor, the actin capping protein
EPS8. This protein is expected to regulate not only local cortical
actin dynamics, but also to maintain IRSp53 in an “open con-
formation”, opposing the inhibitory actions of 14-3-323,60. This
might facilitate the association of IRSp53 with Ptdins(4,5)P2-rich
membranes, and also with activated CDC42 and inactive RAB35.
In keeping with this concept, removal of EPS8 not only pheno-
copies the loss of IRSp53 in cystogenesis assays, but also results in
redistribution of IRSp53, which loses its continuous apical pat-
tern, and becomes concentrated at tight junctions in association
with ZO-1. The importance of the interaction between IRSp53
and activated CDC42 is underscored by the observation that a
single-point mutation in the CDC42 binding site of IRSp53 fails
to rescue the phenotype in IRSp53-KO MDCK and Caco-2 cells.
In addition, in vitro, IRSp53 loss mimics the removal of
CDC4226,61,62, which leads to the formation of multiple lumens.
Of note, the loss of CDC42 also disrupts the orientation of the
spindle in dividing cells during cystogenesis26,61,62 and controls
the trafficking of polarized determinants. Both of these altered
processes are thought to be responsible for the aberrant formation
of multiple lumens. Within this context, IRSp53, which directly
binds to CDC42, might mediate some of these specific functions.
Consistent with this, trafficking of PODXL was perturbed and
IRSp53 localized to PODXL-positive recycling endosomes. Fur-
ther, the loss of IRSp53 significantly altered the spindle orienta-
tion during Caco-2 cystogenesis, to an extent and in a fashion not
dissimilar from those seen after the loss of CDC42 (data not
shown). While the precise mechanisms through which IRSp53
applies this multiple-level regulation remains to be defined, the
most parsimonious interpretation of our findings is that IRSp53
acts as an important CDC42 effector, during both spindle
orientation and polarized membrane trafficking.
In addition to this role, the localization of IRSp53 at the AMIS
and its interaction with RAB35 suggests that it is also part of a set
of molecular cues that define the identity of, and ensure the
structural integrity of, the future apical membrane. Here, IRSp53
Fig. 5 IRSp53 directly binds RAB35 in its inactive GDP-bound state. a Lysates (1 mg) of HeLa cells transfected with GFP-RAB35 and Flag-IRSp53, serum
starved overnight and treated (+) or not (−) with growth factors, were subjected to immunoprecipitation with anti-Flag (Flag) or control (Ctr) antibodies.
Inputs (20 µg) and IPs were analyzed by immunoblotting with the indicated antibodies. pAKT was used for the positive control for growth factor
stimulation. b Structure function analysis. Equal amounts (50 nM) of recombinant purified IRSp53 full-length WT or the indicated fragments and mutant
were spotted onto nitrocellulose and incubated with recombinant purified GST-RAB35S22N (50 nM). After washing, nitrocellulose membranes were
immunoblotted with an anti-GST antibody. c Indicated amounts of recombinant GST-RAB35S22N were spotted onto nitrocellulose and incubated with
equal amounts (30 nM) of either recombinant purified IRSp53 WT or IRSp53 I-BAR* (K142E, K143E, K146E, K147E). After washing, nitrocellulose
membranes were immunoblotted with an anti-IRSp53 antibody. BSA (100 nM) was used as the negative control. d Cell lysates (2mg) from MDCK cells
transfected with GFP empty vector, GFP-IRSp53 wild-type (WT), GFP-IRSp53 I-BAR*, and RFP-RAB35S22N were subjected to immunoprecipitation with
anti-GFP (GFP) or control (Ctr) antibodies. Inputs and IPs were immunoblotted with the indicated antibodies. e Top: MDCK IRSp53-KD or IRSp53-KD cells
were infected to express murine GFP-IRSp53 wild-type (WT), I-BAR*(K142E, K143E, K146E, K147E), CRIB* (I268N), SH3* (I403P) and PDZ* (V522G), and
were seeded as single cells on a Matrigel layer and left to grow for 24/36 h. The cysts were fixed and stained with anti-β-catenin (green) or anti-PODXL
(red) antibodies, and DAPI (blue), or processed for epifluorescence to visualize GFP-IRSp53 (green), and stained with an anti-PODXL antibody (red) and
DAPI (blue). Asterisks, PODXL multi-foci. Scale bar, 10 µm. Bottom left: Quantification of multi-foci cysts. Data are means ± SD. Three/ four-cell stage
cysts were analyzed, as at least 20 cysts/experiment in n= 5 (IRSp53-KD) and n= 2 (WT, I-BAR*, CRIB*, SH3*, PDZ*) independent experiments. P value,
student’s t-test two-tailed. *p < 0.05; **p < 0.01. Source data are provided as a Source Data file. Bottom right: Immunoblotting to detect IRSp53, GFP-
IRSp53 wild-type and mutants, and vinculin.
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might act as a stabilizing factor for RAB35, either directly through
protein:protein interactions, or indirectly through sensing and
enhancing the concentration of PtdIns(4,5)P221, to which RAB35
is known to associate63. In this latter respect, it is worth noting
that: (i) as for the loss of RAB35 that was recently demonstrated
to function as a PODXL tethering factor at the AMIS7, also the
loss of IRSp53 disrupts the correct apical distribution of PODXL;
(ii) the binding to RAB35 and Ptdins(4,5)P2-rich membrane is
mediated by the I-BAR domain. In addition, a mutant in the key
positively charged patches of this domain that disrupts the
interaction of IRSp53 with Ptdins(4,5)P2-rich lipid bilayers37 as
well as the binding to RAB35 failed to correctly localize apically
and to rescue the multi-lumen phenotype in the IRSp53-KO cysts;
(iii) IRSp53 ablation impairs RAB35 localization at the nascent
AMIS, which demonstrates that IRSp53 drives the correct loca-
lization of RAB35. An equally plausible, although not mutually
exclusive, possibility is that in addition to binding to inactive
RAB35 along the AMIS, IRSp53 might associate with regulators
of the RAB35 GTPase, including GEFs or GAPs, to thus con-
tribute to the regulation of its activity. Our proteomic studies
using IRSp53–BirA approaches that can detect transient inter-
actions64, however, failed to identify any of these proteins
{deposited at PASS01464, for details see Methods}, which would
argue against this mode of action. Finally, it is of note that also
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other I-BAR domain family members, IRTKS and MIM, have
been shown to interact with RAB GTPases and to be involved in
endocytosis65. Thus, the involvement in membrane trafficking
appears to be a more general emerging function of the I-BAR
family proteins.
Ultimately, the multiple functional roles of IRSp53 are likely to
be integrated with its sensing and shaping of the flat plasma
membrane at the nascent lumen via its I-BAR domain. Here,
IRSp53 appears to be crucial in the control of the integrity,
continuity, and shape of the opposing plasma membrane. Indeed,
its loss leads to the formation (or preservation) of bridges
between the apical domains of the plasma membrane, which
interrupt the continuity of the nascent lumen (Fig. 10). It appears
reasonable to propose that it is exactly this structural, membrane
role in combination with its control of the trafficking of key
polarity determinants that accounts for its involvement in lumen
formation and tubule morphology.
Whatever the case, all in all, our findings are consistent with a
multifaceted role for IRSp53 that is crucial to ensure the struc-
tural integrity and shape of the plasma membrane, and to coor-
dinate the trafficking of apical proteins to the AMIS. They further
support the concept that IRSp53 acts as a platform where traf-
ficking determinants (e.g., RAB35), actin regulatory proteins (e.g.,
EPS8), and the small GTPase that is critical for polarity (i.e.,
CDC42) are assembled for the correct coordination of diverse
processes during tubule morphogenesis and the establishment of
renal tubular architecture in different species.
Methods
All mice have been maintained in a controlled environment, at 18–23 °C, 40–60%
humidity and with 12-h dark/12-h light cycles, in a certified animal facility under
the control of the institutional organism for animal welfare and ethical approach to
animals in experimental procedures (Cogentech OPBA). All animal studies were
conducted with the approval of Italian Minister of Health (598/2015-PR and 219/
2016-PR) and were performed in accordance with the Italian law (D.lgs. 26/2014),
which enforces Dir. 2010/63/EU (Directive 2010/63/EU of the European Parlia-
ment and of the Council of 22 September 2010 on the protection of animals used
for scientific purposes).
Antibodies, plasmid and reagents. A list of antibodies, details on their applica-
tion and working dilutions are provided in Supplementary Tables 1 and 2.
pFUW-GFP, pFUW-GFP-IRSp53 WT and I-BAR*(K142E, K143E, K146E,
K147E), CRIB* (I268N), SH3* (I403P) and PDZ* (V522G) mutants were a gift
from Hans-Jürgen Kreienkamp, University of Hamburg; pRK5 Flag-IRSp53 was a
gift from Sonia Krugmann; pRRL-GFP-Eps8 was generated by sub-cloning GFP-
Eps8 in pRRL lentiviral vector66; pApple-Rab11a was a gift from Keith Mostov;
GFP- and RFP-RAB35 WT, -RAB35 S22N and -RAB35 Q67L were kind gifts from
Cécile Gauthier-Rouviere, Centre de Recherche en Biologie cellulaire de
Montpellier; pGEX-RAB35-S22N, RAB35-Q67L were generated by sub-cloning
GFP-RAB35-Q67L, -RAB35-S22N in pGEX6P1 vector; RFP-PODXL was a gift
from Fernando Martín-Belmonte, Centro de Biología Molecular Severo Ochoa,
Madrid.
MDCK IRSp53 shRNAmir inducible cell line were a gift from Ann Musch and
were described elsewhere24.
Cell culture. MDCK cells were grown in Dulbecco’s Modified Eagle Medium
(DMEM, Lonza) supplemented with 5% South American serum (EuroClone) and
2mM L-Glutamine (EuroClone). MDCK TetOFF cells were grown in Dulbecco’s
Modified Eagle Medium (DMEM, Lonza) supplemented with 5% South American
serum (EuroClone), 2mM L-Glutamine (EuroClone); controls were maintained in
the presence of 1 μg/ml tetracycline (Sigma) to repress IRSp53 RNAi. Caco-2 cells
were grown in Modified Eagle Medium (MEM, Biowest) supplemented with 20%
South American serum, 2mM L-Glutamine and 0.1 mM NEAA. HEK 293-T cells
were grown in Dulbecco’s modified Eagle’s medium (DMEM, Lonza) supple-
mented with 10% South American serum (EuroClone) and 2mM L-Glutamine
(EuroClone). Cells were grown at 37 °C in 5% CO2. HeLa cells were grown in
Minimum Essential Medium (MEM Invitrogen) supplemented with 10% South
American serum (EuroClone), 1% non-essential amino acids and 1% Sodium
Pyruvate.
Transfection. Transfections were performed using the calcium phosphate method
or liposoluble agents JETPrime (POLYPlus), INTERFERin (POLYPlus) and
FugeneHD (Promega).
293 T cells were transfected using the calcium phosphate procedure. In this case
DNA (10 µg for a 10 cm plate) was diluted in 439 µl of ddH2O and 61 µl of 2 M
CaCl2 were added. This solution was added, drop-wise, to 500 µl of HBS 2×(50 mM
Hepes pH 7.5, 10 mM KCl, 12 mM dextrose, 280 mM NaCl, 1.5 mM Na2HPO4).
Then, the precipitate was added to the cells and the medium replaced after 12–16 h.
JETPrime (POLYPlus) was used, according to manufacturer’s instruction, to
transfect MDCK cells with fluorescent-tagged CRISPR/CAS9 plasmid carrying
sgRNA sequences, and fluorescent or tagged proteins for IF or IP experiments.
INTERFERin (POLYPlus) was used, according to manufacturer’s instruction, to
transfect MDCK cells for transient RNAi interference experiments.
FugeneHD (Promega) was used, according to manufacturer’s instruction, to
transfect CACO2 with fluorescence-tagged CRISPR/CAS9 plasmid carrying sgRNA
sequences.
CRISPR/CAS9 genome editing. MDCK and Caco-2 transiently transfected
with fluorescent-tagged CRISPR/CAS9 plasmid carrying sgRNA sequences (see
below for sgRNA sequences and analysis of the lesions introduced); 48 h after
transfection cells were sorted by FACS and re-cultured. Mass population were
subjected to WB and IF analysis to verify the extent of KO. Clones were then
derived by serial dilution. Analysis of the lesions introduced was performed
by PCR.
MDCK
sgRNA:
WT 5′-GGCAGCAGGCCTGCGCCGACCCCAACAAGATCCCAGACCGC
GCGGTGCAG-3′.
Sequence analysis:
Allele1
5′-GGCAGCAGGCCTGCGTCCGACCCCAACAAGATCCCAGACCGC
GCGGTGCAG-3′.
Allele2
5′-GGCAGCAGGCCTGC - - CGACCCCAACAAGATCCCAGACCGCGC
GGTGCAG-3′.
Both mutations cause the premature termination of the protein at the end of the
I-BAR domain.
Fig. 6 Membrane- and SH3-mediated interactions guide IRSp53 localization. a Seven days-old 3D cysts from Caco-2 IRSp53-KO #3 cells stably infected
with murine GFP-IRSp53 WT, I-BAR*, CRIB*, SH3*, PDZ* were processed to visualize GFP-IRSp53 (green) and stained with an anti-ZO-1 antibody
(magenta), rhodamine-phalloidin to detect F-actin (red), and DAPI (blue). Arrowheads indicate IRSp53 I-BAR* and SH3* at ZO-1-junctions. Scale bar, 10
µm. b Top: 1 day-old 3D cysts from MDCK wild-type control (Ctr) or IRSp53-KO cells stably expressing RFP-RAB35 were processed to visualize RFP-RAB35
(red), stained with anti-PODXL (green) and anti-β-catenin (magenta) antibodies, and DAPI (blue). PODXL and RFP-RAB35 signals were analysed using
masks (in yellow) to quantify RFP-RAB35 localization at the AMIS. Bottom: Quantification of RFP-RAB35 at the AMIS expressed as the ratio of RFP-RAB35
at the AMIS/ RFP-RAB35 out of the AMIS. Data are means ± SD. At least 15 cysts/ experiment were analyzed in n= 2 independent experiments. P value,
student’s t-test two-tailed. ***p < 0.001. Source data are provided as a Source Data file. Scale bar, 10 µm. c Top: Lysates of MDCK control (Ctr) or IRSp53-
KO (KO) transfected with myc-RAB35-WT or MDCK wild type transfected with myc-RAB35-67L were subjected to in vitro pull down with 0.2 μM of
recombinant purified GST-RBD or GST as control. Inputs and IVBs were analysed by Ponceau to detect GST or GST-RBD purified proteins, and subjected to
Western blotting with the indicated antibodies. Bottom: RAB35 levels quantified using ImageJ software were expressed relative to the levels of active-GTP
bound RAB35 in MDCK wild type samples. Data are means from n= 2 independent experiments. d Seven day-old 3D cysts from Caco-2 Eps8-KO #7 cells
infected with murine GFP-IRSp53 wild-type were processed to visualize GFP-IRSp53 (green), stained with an anti-ZO-1 antibody (magenta), rhodamine-
phalloidin to detect F-actin (red), and DAPI (blue). Right panels represent 4× magnification of the area depicted by the dashed square (Left). Arrowheads,
re-localization and enrichment of IRSp53 at the ZO-1–labeled cell–cell junctions. Scale bar, 20 µm. e Schematic of the functional interactions of IRSp53 with
RAB35 and EPS8 at the AMIS. The IRSp53 domains required for its localization and activity on PODXL trafficking.
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Fig. 7 Loss of IRSp53 alters the opposing plasma membranes at the nascent AMIS. a MDCK Ctr (top) and IRSp53-KO cells (middle) were seeded as
single cells on Matrigel-coated gridded coverslips. The cysts were fixed 16 h after seeding, stained with anti-ß-catenin (green) and DAPI (blue). Two-cell
stage cysts were initially identified on grids by confocal microscopy. Scale bar, 10 µm. Samples were then processed for electron microscopy, with images
of the corresponding cells shown at the indicated magnifications. Arrowheads, inter-cytoplasmic bridges of the plasma membranes along the AMIS.
Bottom: Quantification of the inter-cytoplasmic bridges/µm. Two-cell stage cysts were analysed from n= 2 independent experiments. In all, n= 484 (Ctr)
and n= 332 (KO) different fields from n= 6 (Ctr; KO) samples were counted from serial sections along the Z-axis. Data are means ± s.e.m. P value,
student’s t-test two-tailed. ***p < 0.001. Source data are provided as a Source Data file. b Images of a three-dimensional tomographic reconstruction of an
inter-cytoplasmic bridge at the opposing membranes of MDCK IRSp53-KO cells during early cystogenesis (see also Supplementary Movie 4). Arrowheads,
inter-cytoplasmic bridge.
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Fig. 8 Loss of IRSp53 causes defects in pro-nephric ducts and in adult kidneys in zebrafish. a Digital light sheet confocal images of 72 hpf pronephric
ducts. Embryos obtained from either wild-type (b2a WT) or baiap2a (b2a −/−) mutant females in a Tg(CldnB:GFP) genetic background were treated with
scrambled morpholino (b2a WT; b2a −/−) or with spliced and translation blocking morpholinos (b2a WT b2b_Mo; b2a −/− b2b_Mo), and fixed and
mounted in agarose. Samples were stained with an anti-GFP antibody (green) and DAPI (blue). Z-stack projections (magnification, 3.4×) are shown on the
right for the dashed, rectangular boxes on the left. Arrowhead, extra-duct structure in the b2a −/− b2b_Mo embryo. Scale bars, 10 µm. Two-thirds of the
b2a −/− b2b_Mo embryos showed such defects (n= 8/12). b) Hematoxylin and eosin staining of adult zebrafish kidneys. Adult wild-type (b2a WT) and
b2a −/− strains were fixed, decalcified, and paraffin embedded. Bottom: Magnification (2×) of the light green dashed boxes from the upper images. Renal
tubules are surrounded by yellow dashed lines. Arrowheads, abnormal disarrayed and not patent tubules in the b2a −/− sample, characterized by the
irregular distribution and shape of the nuclei; asterisks, vascular lacunae; arrows, infiltrating cells. In all, 70% of the b2a −/− samples show such defects
(n= 7/10) versus ~10% of the b2a wild-type (n= 1/9). Scale bar, 50 µm.
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Caco-2
sgRNA:
5′-AAGCAGGGCGAGCTGGAGAATTACGTGTCCGACGGCTACAAG
ACCGCACT-3′.
Clone #3:
Allele1
5′-AAGCAGGGCGAGCTGGAGAATTACG - - - - - - ACGGCTACAAGAC
CGCACT-3′.
Allele2
5′-AAGCAGGGCGAGCTGGAGAATTACG - - - - - - A - - GCTACAAGACC
GCACT-3′.
Allele3
5′-AAGCAGGGCGAGCTGGAGAATTACGTGT - - - - - - - CTACAAGACC
GCACT-3′.
Deletion in Allele 1 causes the translation of a protein lacking 2aa within the I-
BAR (179-180). Deletion in Allele 2 causes premature termination of the protein at
the end of the I-BAR domain (aa 311). Deletion in Allele 3 causes premature
termination of the protein within the I-BAR domain (aa 184).
Clone #12
Allele1
5′-AAGCAGGGCGAGCTGGAGAATTACG - - - - - - - - - GCTACAAGACC
GCACT-3′.
Allele2
5′-AAGCAGGGCGAGCTGGAGAATTACGTGTC - GACGGCTACAAGACC
GCACT-3′.
Allele3
5′-AAGCAGGGCGAGCTGGAGAATTACG - - - - - - ACGGCTACAAGACC
GCACT-3′.
a
b
R
en
al
 a
lte
ra
tio
n 
sc
or
e
0
5
10
15
20
WT IRSP53-KO
Glomerular phenotypeTubular phenotype
WT
KO
Fig. 9 Genetic removal of IRSp53 leads to defects in murine kidney morphology. a Hematoxylin and eosin staining of kidneys explanted from wild-type
(WT) and IRSp53-KO adult mice were fixed, processed and paraffin embedded. Left: Low magnification images. Right: magnified images of the red (tubular
phenotype) and blue (glomerular phenotype) boxes on the left. Black arrowheads, abnormal irregular distributions and shapes of the nuclei in the IRSp53-
KO kidneys; yellow ellipses, areas with disarrayed and convoluted tubules; yellow arrowheads, glomerular tuft microcystic alterations. Scale bar, 50 µm.
b Quantification of the renal alteration score. Kidneys from wild-type (WT) and IRSp53-KO mice were analyzed and scored for defects in renal morphology
(see also Fig. S9B and Methods). Data are means ± SD. WT, n= 8 (4M, 4 F); KO, n= 16 (6M, 10 F). P value, student’s t-test two-tailed. ***p < 0.001.
Source data are provided in Supplementary Fig. 10 B and as a Source Data file.
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Deletion in Allele 1 causes the translation of a protein lacking 3aa (179-180-
181). Deletion in Allele 2 causes premature termination of the protein within the I-
BAR domain (aa 186). Deletion in Allele 3 causes the translation of a protein
lacking 2aa within the I-BAR (179-180).
PAM sequence; gRNA sequence.
Short interfering RNA (siRNA) experiments. siRNAs (small interfering RNAs)
delivery was achieved by mixing from 5 to 50 nM of specific siRNAs with
INTERFERin Transfection Reagent (POLYPlus) according to manufacturer’s
instruction. For each RNA interference experiment, negative control was per-
formed with the same amounts of scrambled siRNAs (si CTR). Knocking down
efficiency was controlled by western blot.
Oligos details as follows:
IRS 302 CCAAGGAACUCGGAGACGUUCUCUU (Invitrogen).
IRS 749 CAUAGUGGCAGUUUCUGUGCCAGCA (Invitrogen).
RAB35-1 AGAAGAUGCCUACAAAUUCUU (Invitrogen).
RAB35-2 GCUCACGAAGAACAGUAAAUU (Invitrogen).
Lentiviral infections. GFP and GFP-IRSp53 WT or mutants were transduced into
MDCK, Caco-2, Huvec and mEC cells by lentiviral infection using pFUW-based
plasmids. Lentivirus was produced transfecting HEK 293 T cells with 25 µg of
pFUW- or pLLRsin-based constructs, 9 µg ENV, 16.25 µg pMDL, 6.25 µg REV (for
virus packaging). Forty-eight and 72 h after transfection, supernatants were col-
lected and passed through a 0.45 µm filter. Supernatants collected at 48 and 72 h
were added to cells and medium was changed after 6 h. GFP and GFP-IRSp53 WT
and mutants and GFP Eps8 expression was controlled by WB and IF.
Cyst Matrigel culture. MDCK cells were trypsinized to a single cell suspension at
4 × 104 cells/ml in complete medium containing 2% Matrigel (BD Biosciences).
Cell-medium-Matrigel suspensions (250 µl) were plated into µ-Slide 8 well ibiTreat
chambers (Ibidi, 80826), precoated with 15 µl of Matrigel (10 mg/ml). For long
cultures, medium was replaced every 2 days. Cells were grown at different time
points before fixation in 4%paraformaldehyde (PFA).
Cyst Matrigel/collagen culture. Caco-2 cells were trypsinized to a single cell
suspension at 6 × 104 cells/ml and mixed with 20 mM HEPES pH7.5, 1 mg/ml
Collagen I (Corning®), 50% Matrigel (BD Biosciences). Final volume was adjusted
with complete medium containing. Cell-Matrix-medium suspensions (250 µl) were
plated into µ-Slide 8 well ibiTreat chambers (Ibidi, 80826), and left in the incubator
at 37 °C for at least 30 min to allow the mix to solidify through polymerization of
Collagen I and Matrigel. The solidified mixture was then supplemented with 250 µl
of complete medium. Cells were grown at different time points before fixation in
2%paraformaldehyde (PFA). For long cultures, medium was replaced every 2 days.
To speed-up lumen formation in mature cysts, Cholera Toxin (0.1 µg/ml;) was
added at day 6 and cysts culture fixed at day 7.
Immunofluorescence. Cells were plated on glass coverslips (pre-incubated with 0.5%
gelatin in PBS at 37 °C for 30min). Cells were processed for epifluorescence or
indirect immunofluorescence microscopy as follow. Cells were fixed in 4% paraf-
ormaldehyde for 10′, washed with PBS and permeabilized in PBS 0,1% Triton X-100
for 10min at room temperature (RT). To prevent non-specific binding of the anti-
bodies, cells were then incubated with PBS in the presence of 1 % BSA for 10min.
The coverslips were then gently deposited, face down, on 50 µl of primary
antibody diluted in PBS 1% BSA, spotted on Parafilm. After 40min of incubation at
RT, coverslips were transferred into 12 well plates and washed three times with PBS.
Cells were then incubated for 40min at RT with the appropriate secondary antibody.
F-actin was detected by staining with FITC or TRITC-conjugated phalloidin
(Molecular Probes) at a concentration of 6.7 U/mL. After three washes in PBS,
coverslips were transferred into 12 well plates and incubated in PBS containing DAPI
(1:3000) for 5 min at RT. Coverslips were washed three times in PBS coverslips and
mounted in Mowiol (20% Mowiol (Sigma), 5% Glycerol, 2.5% DABCO (Molecular
Probes), 0.02% NaN3 in PBS) and examined by fluorescent optical microscopy or in
a 90% glycerol solution containing diazabicyclo-(2.2.2) octane antifade (Sigma) and
examined under confocal microscope (see below for further information regarding
confocal microscopes). Confocal image acquisition was performed in sequential
mode to limit channel cross-talk and corrected for residual fluorescence bleed
through. Images were further processed with the Image J software (Adobe).
Immuno-fluorescence of MDCK cysts. Cysts seeded on Matrigel into µ-Slide 8
well ibiTreat chambers were fixed at different time point after seeding in PBS 2%
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Fig. 10 Model of how IRSp53 controls nascent lumen formation in epithelial tubular tissues. Control MDCK cells plated on Matrigel in Matrigel-
containing media undergo symmetry-breaking events immediately after the first cell division, when after cytokinetic furrow ingression a midbody is
formed4. Around the midbody, the apical membrane initiation site (AMIS) is assembled establishing the location of the nascent lumen. AMIS assembly
requires the polarized transport of highly-charged and -glycosylated transmembrane proteins, such as Podocalyxin (PODXL), that from the outer cell face
become endocytosed and traffic via vesicular recycling carriers to the newly formed opposing plasma membrane. At this site, repulsive charges contribute
to generate interconnected mini-lumens (leftmost inset show a Correlative Light Electron Microscopy-CLEM-analysis of MDCK cells capture after the very
first cell division) that will evolve to form a single apical lumen, typical of an epithelial cyst. IRSp53 is required both for directing the trafficking of PODXL
and to ensure its targeting at the AMIS via stabilizing the GTPase RAB35 (not shown), and through its interaction with the actin capping protein Eps8 (not
shown). At the AMIS, IRSp53 through its membrane deforming and curvature sensing I-BAR domain ensures the structural integrity, continuity and correct
shape of the opposing plasma membrane at two-cells stage. Consistent with this, IRSp53 genetic loss leads to interruption of the continuity of the PM at
the AMIS (top rightmost inset, yellow arrowhead indicate membrane discontinuities), with the formation of inter-cytoplasmic bridges, and occasionally
ectopic lateral lumen (bottom inset, magenta line outlines the intervening PM and the extra lumen).
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PFA for 20 min, washed 3 times in PBS 1% Glycine (quenching) and left 2 days in
PBS 1x at 4 °C. Cysts were permeabilized in PBS+ 0.5% Triton X-100 and quickly
washed in IF-buffer (PBS, 0.2% Triton X-100, 0.1% BSA, 0.05% Tween). Samples
were then incubated in blocking solution (IF-buffer + 5% BSA) for 1 h and 30 min.
After 1 wash in IF-buffer, cysts were incubated with primary antibodies in IF-
buffer, overnight at 4 °C. Samples were washed 3 times in IF-buffer (5 min each)
and incubated with the appropriate secondary antibody and/or phalloidin for 1 h
and 30 min in the dark. After 1 wash in IF-buffer (5 min) and 2 washes in PBS
samples were incubated with Dapi (5 min). Samples were washed 2 times in PBS
and them left in PBS for confocal analysis. Images were acquired with confocal
microscopes of the Leica SP series (see below for the detailed information)
equipped with a HCX PL APO 40×/0.75–1.25 oil immersion objective.
Immuno-fluorescence of Caco-2 cysts. Cysts embedded in Matrigel/Collagen I
into µ-Slide 8 well ibiTreat chambers were fixed at different time point after seeding
in PBS 2% PFA for 20 min, washed 3 times in PBS 1% Glycine (5 min each), 1 time
in PBS and left 2 days in PBS, 0.03 % NaN3 at RT. Cysts were permeabilized in PBS
+ 0.5% Triton X-100 and rinsed 3 times in PBS (5 min each). Blocking was per-
formed in IF-buffer (PBS 0.2% Triton X-100, 0.05% Tween 20, 0.1% BSA, 0.03%
NaN3) + 10% Goat serum for 1 h. Cysts were incubated with primary antibodies in
IF-buffer, overnight at 4 °C. Samples were washed 3 times in IF-buffer (5 min each)
and incubated with the appropriate secondary antibody and/or phalloidin in IF-
buffer for 1 h in the dark. Samples were washed 3 times in IF-buffer (5 min each) in
the dark, incubated with Dapi (5 min) and rinsed once with PBS for 5 min in the
dark. To reduce the diffusion of antibodies, samples were fixed with 2% PFA for 9
min in the dark at RT. After 3 washes (5 min each) with PBS/glycine in the dark,
samples were rinsed with PBS (5 min) in the dark and stored in PBS in the dark for
confocal analysis. Images were acquired with confocal microscopes of the Leica SP
series (see below for the detailed information) equipped with a HCX PL APO 40×/
0.75–1.25 oil immersion objective.
Podocalyxin trafficking assays. PODXL re-localization at VAC (Vacuolar Apical
Compartment)32,67. MDCK cells were grown in normal medium till confluency.
Monolayers were then washed 3 times in PBS 1×(w/o Ca2+) and cultured in
medium without Ca2+ for 2, 5, 8 h. Cells were then fixed in 4% PFA, permeabi-
lized and subjected to immunofluorescence analysis. In control experiments to test
the anti-PODXL antibody that recognizes the N-Terminal extracellular domain of
the protein (Fig. SI3B), MDCK cells monolayers were pre-incubated with anti-
PODXL antibody for 1 h. After incubation cells were washed 3 time in cold PBS 1x
and fixed in 4% PAF for 10 min without permeabilization (−S −P), subjected to
surface stripping with 0.5% acetic acid pH3+ 0.5 M NaCl, washed 3 time in cold
PBS 1x and fixed in 4% PAF for 10 min without permeabilization (+S −P) or
subjected to surface stripping with 0.5% acetic acid pH3+ 0.5 M NaCl, washed 3
time in cold PBS 1×, fixed in 4% PAF for 10 min, and then permeabilized (PBS 1×,
0,1% Triton X-100, 10 min) (+S +P).
RFP-RAB35 localization at AMIS. MDCK cysts WT control or IRSp53-KO, stably
expressing RFP-RAB35, were fixed and processed for epifluorescence to visualize
RFP-RAB35 (red) and stained with anti-PODXL (green), anti-β-catenin (magenta)
and Dapi (blue) and images were acquired with a Leica SP8 confocal microscope
equipped with a HCX PL APO 40×/0.75–1.25 oil immersion objective. PODXL
staining at AMIS and RFP-RAB35 staining were adopted to design, using ImageJ
software, masks contouring the AMIS and the whole cell body (in yellow). The area
of the AMIS was subtracted to the area of the whole-cell bodies to obtain the “non
AMIS” cell area. RFP signal (Integrated density) was determined for each cell using
ImageJ software in the AMIS vs “non AMIS” area. RFP-RAB35 ratio was calculated
by dividing the signal at the AMIS over the signal of the “non AMIS” area.
Confocal spinning-disc time-lapse microscopy. MDCK cells were seeded as
single cells on Matrigel-coated coverslips in complete medium containing 2%
Matrigel (BD Biosciences). Supplementary Movie 1. Six hours after seeding, images
were acquired (15 h, 5 min time interval) with the UltraVIEW VoX (Perkin Elmer)
spinning disk confocal unit. Images were acquired with a 60X oil immersion
objective (Nikon PLANApo VC 1.4 NA). Supplementary Movies 2 and 3. Six hours
after seeding, images were acquired (15 h, 5 min time interval) using a Confocal
Spinning Disk microscope (Olympus) equipped with IX83 inverted microscope
provided with an IXON 897 Ultra camera (Andor), using a 60x UPlanSApo
1.35NA objective. The system is driven by the Olympus CellSens Dimension
1.18 software (Build 16686). The experiments were performed using an environ-
mental microscope incubator (OKOLab) set to 37 °C and 5% CO2 perfusion.
Correlative light and electron microscopy (CLEM). MDCK cells were trypsinized
to a single cell suspension at 4 × 104 cells/ml in complete medium containing 2%
Matrigel (BD Biosciences). Cell-medium-Matrigel suspensions (350 µl) were plated
into 35mm dish with gridded coverslips (MatTek Corporation, P35G-1.5-14-CGRD),
pre-coated with 20 µl of Matrigel (10mg/ml). 2% Matrigel complete medium was
added to 2ml. After 16–18 h cells were fixed with 150mM Hepes pH 7.5, 4% PFA,
0.05% Glutaraldehyde (5min RT) and 150mM Hepes pH 7.5, 4% PFA (10min RT—
3 times). Cells were then washed with PBS 1×(5min RT—3 times), blocked and
permeabilized in PBS 1×, 1% BSA, 0.1% Saponin (1 h 30min RT). Primary antibody
was then added in PBS 1×, 1% BSA, 0.1% Saponin (4 h RT). After 3 washes in PBS 1X
cells were incubated with secondary antibody (+ Dapi) in PBS 1×, 1% BSA, 0.1%
Saponin (2 h RT) then washed in PBS 1×(3 times) and kept in PBS.
Samples were analyzed with SP8 confocal microscope (20X dry 0.55 NA
objective) to identify cells of interests on the gridded coverslips. After selection
samples were fixed with 4% paraformaldehyde and 2,5% glutaraldehyde (EMS,
USA) mixture in 0.2 M Sodium Cacodylate pH 7.2 for 2 h at RT, followed by 6
washes in 0.2 M Sodium Cacodylate pH 7.2 at RT. Then cells were incubated in 1:1
mixture (volume:volume) of 2% osmium tetra oxide and 3% potassium
ferrocyanide (final concentration 1% osmium tetra oxide and 1.5 % potassium
ferrocyanide) for 1 h at RT followed by 6 times rinsing in 0.2 M Sodium Cacodylate
buffer (pH 7.2). Then the samples were sequentially treated with 0.3%
Thiocarbohydrazide in 0.2 M Sodium Cacodylate buffer (pH 7.2) for 10 min and
1% OsO4 in 0.2 M Sodium Cacodylate buffer (pH 6,9) for 30 min. Samples were
rinsed with 0.1 M Sodium Cacodylate (pH 6.9) buffer until all traces of the yellow
osmium fixative have been removed, washed in de-ionized water, treated with 1%
uranyl acetate in water for 1 h and washed in water again68. The samples were
subsequently subjected to de-hydration in ethanol, and embedded in Epoxy resin at
RT and polymerized for at least 72 h in a 60 °C oven.
Immunolabeling with gold particles: Samples, analyzed with SP8 confocal
microscope (20X dry 0.55 NA objective) to identify cells of interests on the gridded
coverslips (as described above), were fixed with a mixture of 4% paraformaldehyde
and 0.05% glutaraldehyde in 0.15 M Hepes for 5 min at RT and then replaced with
4% paraformaldehyde in 0.15M Hepes for 30 min. Afterward, the cells were
washed 3 times in PBS and incubated with blocking solution (0,5 % BSA, 0,1 %
saponin, 0,27 g NH4Cl in 0.2 M HEPES pH 7.2) for 30 min at RT. Then cells were
incubated with primary antibody diluted in blocking solution overnight at 4 °C. On
the following day, the cells were washed 3 times with PBS and incubated with goat
anti-rabbit or anti-mouse Fab’ fragments coupled to 1.4 nm gold particles (diluted
in blocking solution 1:100) for 2 h and washed 6 times with PBS. Meanwhile, the
activated GoldEnhanceTM-EM (Nanoprobes, Yaphank NY, USA) was prepared
according to the manufacturer’s instructions and 100 μl were added into each
sample well. The reaction was monitored by a conventional light microscope and
was stopped after 5-10 min when the cells had turned “dark enough” by washing
several times with PBS. Then cells were fixed, stained and processed as above.
Sectioning: In order to get EM images of the cell of interest, cells were grown in
three-dimensional Matrigel (collagen) matrix, which was prepared in such a way to
get the minimal thickness of the matrix layer (~100 μm). The cells at the early stages
of cystogenesis, as judged by the initial recruitment of PODXL at the AMIS, were
selected during the analysis of the MatTek dish; the optical sectioning and the Z-
stacking were then performed using confocal microscope. During Z-stacking the
distance between the bottom and the surface of the cell was estimated to facilitate the
trimming of the sample after its embedding into Epon, to find our pair quickly and to
economize slot grids. Z-stack images were printed and during trimming of the
pyramid and its sharpening these images were constantly used. Embedded samples
were then sectioned with diamond knife (Diatome, Switzerland) using Leica EM UC7
ultra microtome. In order to start sectioning exactly when the surface of sectioning
reached the cell surface, we used display of the ultramicrotome section counter, which
shows the total advance and the total number of sections cut from the moment of
CLEAR setting. For the trimming and advance to ROI we used the Diatome diamond
trimming blades (trimtool 45, and histo) (Diatome, Switzerland). In order to avoid
mistakes we took into consideration the possible “shrinkage” of the matrix during its
dehydration and embedding into Epon. Thus, when only 3 μm were left before the
beginning of the cell surface we replaced the trimming histo-knife with the Ultra 35
knife (Diatome, Switzerland), and then cut two 200-nm sections and then a small
series of 70 nm sections. This series then was interrupted by two 200-nm sections and
then the same alternating procedure was repeated several times until the moment
when according to our estimation of the deepness of the cell, the cell should be
finished. Sections were analyzed with a Tecnai 20 High Voltage EM (FEI, now
Thermo Fisher Scientific; The Netherlands) operating at 200 kV. Tilt series were
recorded at a magnification of 9600×, 11,500×, 14,500×, 19,000×, or 25,000× using
software supplied with the instrument.
Immune-CLEM: We followed the protocols described in ref. 69. Briefly, an
ultramicrotome (Leica EM UC7; Leica Microsystems, Vienna) was used to cut 60
nm serial thin sections and 200 nm serial semi-thick sections. Sections were
collected onto 1% Formvar films adhered to slot grids. Both sides of the grids were
labeled with fiduciary 10 nm gold (PAG10, CMC, Utrecht, the Netherlands). Tilt-
series were collected from the samples from ±65° with 1° increments at 200 kV in
Tecnai 20 electron microscopes (FEI, now Thermo Fisher Scientific, Eindhoven, the
Netherlands) and recorded at a magnification of 9600×, 11,500×, 14,500×, 19,000×
or 25,000× using software supplied with the instrument. The nominal resolution in
our tomograms was 4 nm, based upon section thickness, the number of tilts, tilt
increments, and tilt angle range. The IMOD package and its newest viewer,
3DMOD 4.0.11, were used to construct individual tomograms and for the
assignment of the outer leaflet of organelle membrane contours, CLEM was
performed as described70.
Immunohistochemistry. Mouse tissues and organs were dissected just after the
mice were sacrificed by CO2 asphyxiation or cervical dislocation.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-17091-x
18 NATURE COMMUNICATIONS |         (2020) 11:3516 | https://doi.org/10.1038/s41467-020-17091-x | www.nature.com/naturecommunications
Human tissue samples were obtained from the University of Palermo, School of
Medicine, Istituto di Patologia Generale, Palermo; the European Institute of
Oncology (IEO), Milano. Human breast cancer tissue samples were collected
according to the Helsinki Declaration and the study was approved by the
University of Palermo Ethical Review Board (approval number 09/2018). The cases
were classified according to the World Health Organization classification criteria of
the Tumors of the Breast.
Four-micrometers-thick sections obtained from paraffin-embedded tissues were
stained with H&E for histomorphological evaluation. For immunostaining, tissue
sections were dewaxed and rehydrated. The antigen unmasking technique was
performed using Novocastra Epitope Retrieval Solutions, pH6 citrate-based buffer
and pH9 EDTA-based buffer in thermostatic bath at 98 °C for 30 min. After the
sections were brought at room temperature, the neutralization of the endogenous
peroxidase with 3% H2O2 and protein blocking by a specific protein block were
performed. For immunostaining on Human kidney, colon, gastric mucosa,
prostate, salivary gland and breast samples, Mouse kidney samples and Zebrafish
kidney samples from wild type IRSp53 and IRSp53 −/− phenotypes, the following
primary antibodies were used: Mouse anti-human IRSp53 (1,5 h at room
temperature, dilution 1:200 pH6), Rabbit anti-mouse IRSp53 (overnight at 4 °C,
dilution 1:50 pH9, HPA023310 Sigma), Rabbit anti-zebrafish IRSp53 (overnight at
4 °C, dilution 1:30, pH9), Rat anti-mouse Endomucin, (overnight at 4 °C, dilution
1:100); Rabbit anti-mouse PKC ζ (overnight at 4 °C, dilution 1:100 pH9, sc-216
Santa Cruz); Rabbit anti-mouse ZO-1 (1 h at room temperature, dilution 1:100
pH9, GTX108592 Genetex). The immunostaining was revealed by either a polymer
detection method (Novolink Polymer Detection Systems Novocastra Leica
Biosystems Newcastle Ltd Product No: RE7280-K) and following specific
secondary antibodies: donkey anti-rabbit IgG (H&L) specific secondary antibody
1:500 (Novex by Life Technologies) and goat anti-rat IgG (H&L) specific secondary
antibody 1:500 (Novex by Life Technologies) and AEC (3-Amino-9-
Ethylcarbazole) substrate was used as chromogen. The slides were counterstained
with Harris hematoxylin (Novocastra, Ltd). In double-marker immunofluorescence
(IF) staining, tissue sections were incubated with the following primary antibodies:
Mouse anti-human IRSp53, (1,5 h at room temperature, dilution 1:200), Rabbit
anti-human ZO-1 (overnight at 4 °C, dilution 1:100 pH9, GTX108592 Genetex)
and Rabbit anti-human Laminin (overnight at 4 °C, dilution 1:25 pH6, ab11575
Abcam). The following secondary antibodies were used: Alexa fluor 568-
conjugated goat anti-mouse, Alexa fluor 488-conjugated goat anti-rabbit (Life
Technologies). Nuclei were counterstained with DAPI (4′,6-diamidin-2-
fenilindolo). Sections were analyzed with: (1) Zeiss Axio Scope A1 optical
microscope (Zeiss, Germany) and microphotographs were collected using an
Axiocam 503 Color digital camera with the ZEN2 imaging software (Zeiss
Germany); (2) Olympus BX63 Upright microscope equipped with a motorized
stage Black and white camera: Hamamatsu Orca AG (12 bit, 6.45 um pixel size)
and Color Camera: Leica DFC450C (36 bit, 3.4 um pixel size); (3) Scan Scope XT
device and the Aperio Digital pathology system software (Aperio; Leica).
Standard Cell lysis for WB analysis. After washing with PBS 1×, cells were lysed
in cell lysis buffer (Hepes pH 7.5 50 mM, NaCl 150 mM, glycerol 1%, Triton X-100
1%, MgCl2 1.5 mM, EGTA 5mM, 1 mM DTT, EDTA-Free PIC) directly on the
plates using a cell-scraper. About 250 μl of buffer/10 cm plates were used. Lysates
were incubated on ice for 10 min and spun at 13,200 rpm for 10 min at 4 °C. The
supernatant was transferred into a new tube and protein concentration was mea-
sured by the Bradford assay (Biorad), following manufacturer’s instructions.
SDS polyacrylamide gel electrophoresis (SDS PAGE). Pre-casted acrylamide
gels (BIORAD or Thermo Fisher Scientific) were employed for resolution of
proteins.
Western blot analysis. Desired amounts of proteins were loaded onto 0.75–1.5
mm thick polyacrylamide gels for electrophoresis (Biorad). Proteins were trans-
ferred in Western transfer tanks (Biorad) to nitrocellulose (Schleicher and Schuell)
in Western Transfer buffer 1×(diluted in 20% methanol) at constant Voltage (100
V for 1 h or 30 V overnight). PonceauS coloring was used to reveal roughly the
amount of proteins transferred on the filters. Filters were blocked 1 h (or overnight)
in 5% milk or 5% BSA in TBS 0.1% Tween (TBS-T).
After blocking, filters were incubated with the primary antibody, diluted in
TBS-T 5% milk, for 1 h at room temperature, or overnight at 4 °C, followed by
three washes of 5 min each in TBS-T and then incubated with the appropriate
peroxidase-conjugated secondary antibody diluted in TBS-T for 1 h. After the
incubation with the secondary antibody, the filter was washed three times in TBS-T
and the bound secondary antibody was revealed using the ECL (Enhanced
Chemiluminescence) method (Amersham).
All uncropped blots can be found in the Source Data file.
Co-immunoprecipitation assay. Lysates prepared in IP buffer (40 mM Hepes
pH7.5, 150 mM NaCl, 10 mM MgCl2, 2 mM EDTA, 0.3% CHAPS, 10 mM NaPyr,
50 mM NaF, 10 mM NaVan, 2 mM PMSF, 1 mM DTT, PIC) were incubated in the
presence the anti-FLAG M2 affinity gel (SIGMA; Fig. 5a), anti-GFP mAb agarose
(MBL; Fig. 5d) or control antibodies (Ctr) for two cycles of 1 h each at 4 °C with
rocking. Immunoprecipitates were washed 3 times in IP buffer. After washing,
beads were resuspended in 1:1 volume of 2× SDS-PAGE Sample Buffer, boiled for
10 min at 95 °C, centrifuged for 1 min and then loaded onto polyacrylamide gels.
Overlay assay. Nitrocellulose membranes were incubated in TBST 0.1% Triton X-
100 buffer and let do dry. Equal or increasing amounts of recombinant-purified
proteins were spotted on membranes and let dry. Membranes, previously blocked
in TBST 0.1% Triton X-100 5% Milk, were then incubated with the recombinant
protein of interest, resuspended in TBST 0.1% Triton X-100 5% Milk, 1–2 h at 4 °C.
After extensive washing in TBST 0.1% Triton X-100, membranes were subjected to
western blot analysis with the desired antibodies.
GST-RAB35/ IRSp53 in vitro binding. GST-RAB35WT was loaded with either
GDP (SIGMA, 1 mM) or GTPγS (SIGMA, 0.2 mM) in loading buffer (25 mM Tris
pH 7.5, 100 mM NaCl, 10 mM EDTA, 5 mM MgCl2, 1 mM DTT), 1 h 37 °C.
Reactions were stopped by adding 20 mM MgCl2. Equal amount (2.5 µM) of GST-
RAB35S22N, GST-RAB35Q67L, GST-RAB35WT-GDP, GST-RAB35-GTPγS or
GST as a control were incubated with 1 µM of recombinant purified His-IRSp53 in
IVB buffer (50 mM Tris pH 7.5, 100 mM NaCl, 10 mM MgCl2, 0.1% Triton X-100,
0.05% BSA), 1 h at 4 °C. Reactions were washed 3 times in washing buffer (IVB
buffer w/o BSA). After washing, beads were resuspended in 1:1 volume of 2x SDS-
PAGE Sample Buffer, boiled for 10 min at 95 °C, centrifuged for 1 min and then
loaded onto polyacrylamide gels.
RBD in vitro binding. Cell lysates from MDCK Ctr or IRSp53-KO transfected with
myc-RAB35WT or MDCK Ctr transfected with myc-RAB35Q67L (lysis buffer: 50
mM HEPES pH 7.2, 150 mM NaCl, 10 mM MgCl2, 1 % Triton X-100, EDTA-free
PIC) were incubated with equal amount (0.2 µM) of GST-RBD or GST as control,
1 h and 30 min at 4 °C. Reactions were washed 3 times in lysis buffer. After
washing, beads were resuspended in 1:1 volume of 2x SDS-PAGE Sample Buffer,
boiled for 10 min at 95 °C, centrifuged for 1 min and then loaded onto
polyacrylamide gels.
GST-fusion and His-fusion proteins production. All the GST and His fusion
proteins used were product in bacteria using E. coli BL21 Rosetta (DE3) competent
cells transformed with the pGEX6P1 or pTRC-His vector in which the desired
construct had been cloned.
Bacterial culture. E. coli BL21 Rosetta (DE3) cells picked from individual colonies,
transformed with the indicated GST-fusion, were used to inoculate 200 mL of LB
medium (containing ampicillin at 50 μg/mL) and were grown overnight at 37 °C.
Between 10 and 100 mL of the overnight culture was diluted in 1 l of LB and was
grown at 37 °C (240 rpm shaking) till it reached approximately OD= 0.4–0.6.
IPTG (1 mM) was then added used to induce the protein production. After the
induction cells were pelleted down at 6000 rpm for 15 min at 4 °C and pellets were
used immediately or conserved at −80 °C after washing in PBS 1×.
GST-fusion protein. Pellets were suspended in GST-lysis buffer (15 mL for 1 L
culture). Samples were sonicated 3 times for 30 s/each on ice and were pelleted
down at 13,200 rpm for 30 min at 4 °C using a JA 20 Beckman rotor or at 40,000
rpm for 45 min at 4 °C using a 55.2 Ti Beckman rotor. A total of 1 mL of
glutathione-sepharose beads (Amersham), previously washed 3 times with GST-
lysis buffer, was added to the supernatant and samples were incubated 1–2 h at 4 °C
while rocking. Beads were then washed 3 times (with 5 min of incubation at 4 °C
each) in the GST lysis solution. GST-proteins were resuspendend 50% slurry in the
GST-lysis solution. The quantification was achieved in an SDS PAGE gel using a
titration curve with BSA.
GST-lysis buffer. 2x TBS
0.5 mM EDTA
10% Glycerol
Protease inhibitor cocktail (Roche, Basel, Switzerland)(freshly added)
1 mM DTT (freshly added).
His-fusion protein. Pellets were resuspended in His-lysis buffer (10 ml every
liter of culture); samples were sonicated 3 times for 30 s/each on ice and were
pelleted down at 13,200 rpm for 30 min at 4 °C using a JA 20 Beckman rotor or
at 40,000 rpm for 45 min at 4 °C using a 55.2 Ti Beckman rotor. A total of 600 µL
of NiNTA beads (Qiagen), previously washed 3 times with His-lysis buffer,
was added to the supernatant and samples were incubated 1–2 h at 4 °C while
rocking. Beads were then washed 2 times in washing buffer 1 and 1 time in
washing buffer 2 (5 min, 4 °C).
Elution. Beads were packed in Poly-Prep® Chromatography Columns (BioRad) and
eluted with Elution buffer (500 µl fractions). Fractions, evaluated by Bradford assay
and SDS-PAGE, were pooled together and buffer exchange with Exchange buffer,
using PD10 columns (GE Healtcare). Samples were diluted 1:2 in Dilution buffer
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and loaded on RESOURCE S cation exchange chromatography column (GE
Healtcare) (settings for ResS run: 1CV buffer A, than gradient 0→50%B 60CV,
fractions: 1.2 ml). Fractions were pulled, concentrated in S200 10/30 column
equilibrated with Modified storage buffer, flash frozen and stored at −80 °C.
His-lysis buffer. 50 mM Tris pH8
300mM NaCl
10 mM imidazole
1 mM ß-mercaptoethanol
proteases inhibitors
10% glycerol
Washing buffer 1. 20 mM imidazole
600 mM NaCl
50 mM Tris pH8
1mM ß-mercaptoethanol
10% glycerol
Washing buffer 2. 40 mM imidazole
300 mM NaCl
50 mM tris pH 8
1mM ß-mercaptoethanol
10% glycerol
Elution buffer. 200 mM imidazole
50 mM Tris pH8
200mM NaCl
1 mM ß-mercaptoethanol
10% glycerol
Exchange buffer. 50 mM Tris pH6.8
100 mM NaCl
5% glycerol
1 mM DTT
0.5 mM EDTA
Dilution buffer. 50 mM Tris pH 6.8
5% glycerol
0.5 mM EDTA
ResS buffer A. 50 mM NaCl
50 mM Tris pH 6.8
5% glycerol
1 mM EDTA
1mM DTT
ResS buffer B. 1 M NaCl
50 mM Tris pH 6.8
5% glycerol
1 mM EDTA
1mM DTT
Modified storage buffer. 50 mM Tris 7.5
200 mM NaCl
1 mM DTT
10% glycerol
SILAC BioID of IRSp53 interactors. BirA* expressing vector was purchased from
Addgene (plasmid # 35700). BirA* was cloned upstream of IRSp53 or GFP, as
control, in lentiviral pLVX vector (Clonetech). HeLa cells were infected with len-
tiviral particles generated from pLVX BirA*-IRSp53 or pLVX-BirA*-GFP. The two
populations have been treated with heavy (BirA*-GFP) and light (BirA*-IRSp53)
labeled DMEM medium for SILAC (Thermo Fisher Scientific) (supplemented with
dialyzed fetal bovine serum) for 6 passages; swap of labeling was performed in the
replicate. Cells have been treated with 50 μM biotin for 24 h and lysed in cell lysis
buffer (Hepes pH 7.5 50 mM, NaCl 150 mM, glycerol 1%, Triton X-100 1%, MgCl2
1.5 mM, EGTA 5mM, 1 mM DTT, EDTA-Free PIC), then biotinylated proteins
were fished out with streptavidin-conjugated magnetic beads (Thermo Fisher
Scientific). Beads were washed out from aspecific binders using 50 mM Tris pH 7.5,
1% SDS and protease inhibitors; elution was performed using SDS-PAGE Sample
buffer 2×, coupled with 95 °C boiling. Eluates were then subjected to SDS-PAGE;
after colloidal blue staining, bands were excised and reduced with 10 mM dithio-
threitol, alkylated with 55 mM iodoacetamide and finally digested overnight with
12.5 ng/μl of trypsin (Roche). After acidification, peptide mixtures were con-
centrated and desalted, dried in a Speed-Vac and resuspended in 12–15 μL of
solvent A (2% acetonitrile, 0.1% formic acid). A total of 5 μl of each digested
sample from the forward and reverse experiments were loaded on a LC (liquid
chromatography)–ESI–MS/MS quadrupole Orbitrap QExactive mass spectrometer
(Thermo Fisher Scientific). Peptides were separated on a linear gradient from 95%
solvent A to 40% solvent B (80% acetonitrile, 0.1% formic acid) over 30 min and
from 40 to 100% solvent B in 3 min at a constant flow rate of 0.25 μl/min on
UHPLC Easy-nLC 1000 (Thermo Scientific), where the LC system was connected
to a 25-cm fused-silica emitter of 75 μm inner diameter (New Objective, Inc.
Woburn, MA, USA), packed in-house with ReproSil-Pur C18-AQ 1.9 μm beads
(Dr Maisch Gmbh, Ammerbuch, Germany). MS data were acquired using a data-
dependent top 12 method for HCD fragmentation. Survey full-scan MS spectra
(300–1650 Th) were acquired in the Orbitrap with 70,000 resolution, AGC target
3e6, IT 60 ms. For HCD spectra, resolution was set to 17,500 at m/z 200, AGC
target 1e5, IT 120 ms; Normalized Collision energy 25% and isolation with 2.0 m/z.
Technical replicates were conducted on the LC–MS-MS part of the analysis. Raw
data were processed with MaxQuant ver. 1.4.1.2. Peptides were identified from the
MS/MS spectra searched against the UniProt_Human_2014_10 database using the
Andromeda search engine in which trypsin specificity was set up with a maximum
of two missed cleavages. Cysteine carbamidomethylation was used as fixed mod-
ification, methionine oxidation and protein N-terminal acetylation as variable
modifications. Mass deviation for MS/MS peaks was set at 20 ppm. The peptides
and protein false discovery rates (FDR) were set to 0.01; the minimal length
required for a peptide was six amino acids; a minimum of two peptides and at least
one unique peptide was required for high-confidence protein identification. The
lists of identified proteins were filtered to eliminate reverse hits and known con-
taminants. For quantitative analysis, “re-quantify” and “second peptide” options
were selected. The statistical program Perseus (ver. 1.5.1.6) was used to quantify
significantly up and downregulated proteins following the criteria: (i) significance
A with a Benjamini-Hochberg FDR < 0.05; (ii) ratio normalized values concordant
in both forward and reverse experiments; (iii) minimum H/L ratio counts = 2.
Proteomic data are available at the PeptideAtlas repository PASS01464.
Zebrafish strains. Adult zebrafish were maintained in a multi-rack system (from
Aquatic Habitats) at a water temperature of 28 °C, pH 7 and conductivity 600 μS.
Zebrafish embryos and larvae not older than 5 dpf were maintained at 28.5 °C in E3
water (50 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl, 0.33 mM MgSO4, 0.05%
methylene blue). Zebrafish strains used in this study are AB (referred to as wild
type) sa11319 obtained from European Zebrafish Resource Center (EZIRC)
referred to as baiap2aC201* and Tg(cldnB:GFP). All the strains were maintained and
bred according to the national guidelines (Italian decree “4 March 2014, n.26”). All
experimental procedures were approved by the FIRC Institute of Molecular
Oncology Institutional Animal Care and Use Committee and Italian Ministry of
Health.
Genomic DNA extraction from zebrafish embryos. Caudal fin biopsies (fin clip)
were incubated 10 min at 98 °C in 50 μl of lysis buffer (Tris-HCl 10 mM pH 8.0,
EDTA 1mM, 0.3% Tween, 0.3% NP40) followed by the ice cooling. A total of 5 μl
of Proteinase K 10 mg/ml (Sigma-Aldrich) were added and samples were incubated
at 55 °C O/N. The second day, 145 μl of sterile water were added, followed by 20 μl
of Sodium Acetate and 200 μl of Phenol. Samples were mixed by inverting them
and centrifuged at 13,000 rpm for 1 min. Supernatant was collected and pre-
cipitated O/N with 100% ethanol at −20 °C. The third day, samples were cen-
trifuged for 30 min at 4 °C and recovered pellets were washed with 75% ethanol,
centrifuged again for 5 min and resuspended in 20 μl of DNAse-free water.
sa11319 genotyping. Genomic DNA (gDNA) was extracted from the caudal fin
biopsies of adult sa13359 fish (generated with ENU at Sanger Institute) and a
fragment of 420 bp containing baiap2a mutation was amplified by PCR with the
specific primers forward 5′-TGTTGAGGCCATCAGCAGTA-3′ and reverse 5′-
CAAACTGTGCCCAATGGAG-3′ and sequenced (Cogentech Sequencing Facil-
ity). Only heterozygous fish were maintained and in-crossed to obtain omozygous
embryos and adult fish.
RNA extraction from zebrafish, cDNA synthesis and RT-PCR. Wild type zeb-
rafish larvae (AB strain) were collected at 2, 6, 24 and 48 hpf and RNA was
extracted using TRIZOL Reagent (Invitrogen) and RNAse Mini kit (QIAGEN). To
avoid genomic DNA contamination, samples were digested with RQ1 RNase-Free
DNase (Promega). The cDNA was retrotranscribed from 1 μg of RNA using
SuperScript VILO cDNA Synthesis kit (Invitrogen), according to manufacturer
instructions. 500 ng of cDNA were used as template for a semi-quantitative RT-
PCR using the following primers: 5′-ACGGAGTGTCTCAGGGAAGA-3′ and 5′-
TTCTCTCCATAGTGCCAGCC-3′ for baiap2a, 5′-TTGGAGAGAAATGGAC-3′
and 5′-CGTGTAGGAGAACGGGAACCA-3′ for baiap2b. β-actin was used as
housekeeping.
Hematoxylin and eosin staining and immunostaining on paraffin sections.
Larvae were fixed O/N at 4 °C in 4% PFA diluted in PBS and positioned in a 7 ×
7 × 6 mm plastic base-molds (Kaltek) containing 1.2% low-melting agarose in PBS.
Before agarose solidification, larvae were correctly oriented. After agarose block
solidification, larvae were removed from the base mold and immersed in 70%
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ethanol. After dehydration, agarose blocks were subjected to paraffin embedding by
Leica ASP300 S Fully Enclosed Tissue Processor and 5 μm thick sections were cut
using a manual rotatory microtome (Leica). Sections were stained with Harris
hematoxilin solution for 2 min, washed in running water for 5 min, counterstained
with Eosin-Y solution for 7 s and washed in running tap water for 5 min. Sections
were dehydrated with 95% ethanol and 100% ethanol for 5 min two times. Then,
they were cleared two times with xylene for 5 min and mounted on a glass slide.
Sections were finally imaged using a Nikon Eclipse 90i microscope, respectively,
with 20X and 100X objectives. For immunostaining, sections were incubated in
sodium citrate buffer (2.94 mg/ml tri-sodium citrate pH 6, 0.05% Tween 20) at 95 °
C for 45 min and cooled at RT for 1 h under chemical hood. Sections were then
incubated in blocking solution (2% fetal bovine serum, 2 g bovine serum albumin,
0.05% Tween 20 in PBS 1X adjusted at 7.2 pH) for 1 h at RT followed by IRSp53
primary antibody diluted in blocking solution O/N. Samples were rinsed in PBS 1X
three times for 5 min. The antibody signal was revealed with DAB and haema-
toxylin staining was performed, then sections were dehydrated and mounted with
Eukitt-mounting medium.
Zebrafish whole-mount IF and sections. Three days post fertilization larvae were
fixed O/N at 4 °C with 4% PFA diluted in PBS 1X and rinsed 3 times with PBS 1×.
Embryos older than 24 hpf were treated with 0.25% trypsin (Sigma-Aldrich) at RT
for a range of time between 2 min (for 24 hpf embryos) up to 60 min (for 5 dpf
larvae). Samples were then rinsed 3 times for 5 min with washing buffer (1%
Triton-X100, 0.2% DMSO in PBS 1×) and incubated for at least 1 h in blocking
buffer (0.1% Triton X-100, 1% DMSO, 5% normal goat serum in PBS 1×) on a
shaker. Subsequently, embryos were incubated with primary antibodies diluted in
blocking buffer O/N at 4 °C. The following day, samples were rinsed rapidly twice
with washing buffer and at least 3 washes of 1–2 h each with washing buffer were
performed. Samples were incubated in blocking buffer for 30 min followed by
secondary antibodies diluted in blocking buffer O/N at 4 °C. The final day, samples
were rapidly rinsed 2 times with washing buffer and two washes of 5 min each with
PBS 1X were performed. Samples were incubated 10 min with DAPI, rapidly rinsed
with PBS 1X and mounted on a glass slide in 85% glycerol. The following primary
antibodies were used: chicken anti-GFP 1:1000 (Abcam, ab13970). Alexa fluor-488
(Invitrogen) were used as secondary antibodies. Pronephric ducts were first
acquired using a Leica SP8 confocal microscope equipped with 63X immersion oil
objective, deconvolved with a Huygens software (Fig. 8a and Supplementary
Movie 5) and then elaborated (Supplementary Movie 5) with a 3D rendering
processing (Scientific Volume Imaging).
Vibratome section. To prepare 80 μm transversal sections, 3 dpf embryos pre-
viously stained were cutted in PBS with a vibratome after inclusion in 5% low-
melting agarose. Sections obtained were equilibrated and mounted in glycerol 85%
in PBS on glass slides and observed under a Leica TC-SP2 confocal microscope.
Paraffin section. 3 dpf embryos were fixed, included and processed as already
described. A total of 4 µm sections were dewaxed and rehydrated. The antigen
unmasking technique was performed using Novocastra Epitope Retrieval Solutions,
pH6 citrate-based buffer in thermostatic bath at 98 °C for 30 min. After that, the
sections were brought at room temperature and stained with chicken anti-GFP
1:1000 (Abcam) and anti-acetyl-α-tubulin 1:500 (Abcam). Alexa fluor-488 and
−561 1:400 (Invitrogen) were used as secondary antibodies and Dapi to counter-
stain nuclei. Images were acquired using a Leica SP8 confocal microscope equipped
with 63X immersion oil objective.
Morpholino injections. Zebrafish embryos were microinjected at 1 cell stage with
an Olympus SZX9 and a Picospritzer III microinjector (Parker Instrumentation).
Injection mixes were composed of Danieau solution 1×(NaCl 58 mM, KCl 0.7 mM,
MgSO4 0.4 mM, Ca(NO3)2 0.6 mM, HEPES 5.0 mM, pH 7.6), Phenol red 0.1% and
Morpholino (MO) antisense oligos (Gene Tools). Each embryo was injected,
respectively, with 1.7 ng of splice-blocking baiap2b MO, 5′-TTCGGGCACTACA
TGAGTGACCTT-3′, and 1.7 ng of 5′-UTR baiap2b MO, 5′-AAAGGTCACTCAT
GTAGTCGCCGAA-3′, together.
Western blot analysis. Larvae were lysed in sample buffer; 40 μg of total extracts
were resolved by SDS-PAGE, transferred to nitrocellulose and tested with the
IRSp53 (1:50) antibody. Band intensities were quantified using ImageJ.
Microscopes
Widefield. Upright Olympus BX51 FL, equipped with 60×
UPlanApo 1.35 NA oil and a Photometrics Cool SnapEZ camera.
Software: MetaVue.
Confocal spinning disk. UltraVIEW VoX (Perkin Elmer) spin-
ning disk confocal unit, equipped with an EclipseTi inverted
microscope (Nikon), a C9100-50 EMCCD camera (Hamamatsu)
and driven by Volocity software (Improvision, Perkin Elmer).
Confocal Spinning Disk microscope (Olympus), equipped with
IX83 inverted microscope, an IXON 897 Ultra camera (Andor)
and driven by the Olympus CellSens Dimension 1.18 software
(Build 16686).
Confocal SP5inv. Leica TCS SP5 laser confocal scanner mounted
on a Leica DMI 6000B inverted microscope equipped with
motorized stage, HC PL Fluotar 10×/0.30NA dry objective, HC
PL FLUOTAR 20×/0.5NA dry objective, HCX PL APO 40×/
1.25–0.75NA oil immersion objective and HCX PL APO 63×/
1.4NA oil immersion objective.
Laser lines available:
405 nm.
Argon Laser (458 nm, 476 nm, 488 nm, 496 nm, 514 nm).
DPSS 561 nm.
HeNe 633 nm.
Software: Leica LAS AF.
Confocal SP2 AOBS. Leica TCS SP2 AOBS laser confocal
scanner mounted on a Leica DM IRE2 inverted microscope.
Objective: HCX PL APO 63×/1.4NA oil immersion objective
and HCX PL APO 40×/1.25–0.75NA oil immersion objective.
Laser lines: Violet (405 nm laser diode), blue (488 nm argon
laser), yellow (561 nm laser diode) and red (633 nm laser diode).
Software: Leica Confocal Software (LCS).
Confocal SP8 white laser. Leica TCS SP8 laser confocal scanner
mounted on a Leica DMi 8 inverted microscope equipped
with motorized stage. Objectives: HC PL APO CS2 20×/0,75
dry objective, HC PL APO CS2 40×/1,30 oil immersion
immersion objective and HC PL APO CS2 63×/1.40 oil
immersion objective.
Laser lines available:
405 nm pulsed.
Argon Laser (458 nm, 476 nm, 488 nm, 496 nm, 514 nm).
White light laser tunable in the range: 470 nm-670 nm.
Software: Leica Application Suite X (LASX) ver. 3.5.2.18963.
Confocal SP8. Leica TCS SP8 laser confocal scanner mounted on
a Leica DMI 8 inverted microscope equipped with motorized
stage. Objectives: HC PL FLUOTAR 20×/0,55 dry objective, HC
FLUOTAR 25×/0,95 water objective, HCX PL APO 40×/
0.75–1.25 oil immersion objective, HC PL APO CS2 63×/1.40 oil
immersion objective.
Lasers:
405 nm diode.
Argon (458 nm, 476 nm, 488 nm, 496 nm, 514 nm).
DPSS 561 nm.
HeNe 633 nm.
Incubation system: Okolab bold line.
Software: Leica Application Suite X, ver. 3.5.1.18803.
Statistical analysis. All data are presented as scatter plots with
bars and the mean of independent biological replicates ± SD, with
the exception of Fig. 7b (n > 300) where the mean ± s.e.m is
reported. The number of experiments as well as the number of
samples analyzed is specified for each experiment and reported in
the figure legends. A two-tails, student’s t-test with Welch cor-
rections for two samples with un-equal variance was used to
calculate the p values, with the exception of Fig. 4b, bottom right
graph, and Fig. 4c, bottom right graph, where a one-tail student t-
test was used. *p < 0.05; **p < 0.01, ***p < 0.001.
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Reproducibility. Experiments such as IB, IF, IHC, ponceau
staining, agarose gel (in Figs. 1a–d, 2a, 3b–d, a, 5a–d, 6a, d, 8a, b,
9a; and Supplementary Figs. 1A–D, 2A–D, 3A–C; 4B–E; 5A–D;
6D, 7A, 8A, B, 9B; 10A, 11A–D) are representative of at least two
independent experiments with similar results, unless otherwise
indicated.
Reporting summary. Further information on research design is
available in the Nature Research Reporting Summary linked to
this article.
Data availability
All full scan immunoblots, gels and all data set used to generate each of the graph
presented in the work are provided in the Source Data file. Specifically, the source data
underlying Figs, 2a–d, 4b, c, 6a, b, 7a, b, 9b and Supplementary Figs. 3d, e, 4a, 6a, b, and
9a are provided as a Source Data file. The authors declare that all of the data that support
the findings of this study are available within the paper and its Supplementary
Information files, and from the corresponding authors upon reasonable request.
Proteomic data have been deposited and are available at the PeptideAtlas repository
PASS01464. Source data are provided with this paper.
Received: 6 November 2019; Accepted: 11 June 2020;
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